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ABSTRACT			 Arterial	thromboembolism	(ATE)	is	a	devastating	and	life-threatening	condition	in	cats	most	commonly	secondary	to	heart	disease.	Echocardiography	is	the	reference	standard	to	evaluate	for	presence	of	a	clot	or	its	precursor	known	as	spontaneous	echocardiographic	contrast	(SEC	or	“smoke”)	within	the	left	atrium	and	left	auricle.	In	humans,	trans-esophageal	echocardiography	(TEE)	is	the	gold	standard,	however	computed	tomographic	angiography	(CTA)	is	becoming	more	widely	used	to	assess	detection	of	left	atrial	thrombi	precluding	the	use	of	sedation.	The	purpose	of	this	prospective	study	is	threefold.	The	first	objective	is	to	compare	echocardiography	and	CTA	(also	dynamic	versus	continuous	phase)	in	their	abilities	to	identify	and	characterize	cardiac	clots	from	smoke	in	awake	cats.	Our	second	objective	is	to	maximize	prognostic	indicators	and	comorbidities	(e.g.	congestive	heart	failure,	heart	chamber	enlargement,	clots,	pulmonary	pathology)	provided	on	an	emergency	basis	or	when	a	cardiologist	(or	echocardiography)	is	unavailable.	Our	third	objective	is	to	ensure	this	protocol	is	safe	in	cats	with	heart	disease	and	congestive	heart	failure.	Cats	with	smoke	or	clot	were	recruited	and	an	echocardiogram	and	CTA	(continuous	phase	and	dynamic)	were	performed	within	24	hours.	A	total	of	14	cats	were	included	(7	with	clots	and	7	with	smoke)	based	on	original	echocardiographic	images.	All	but	one	(6/7,	85.7%)	of	the	clots	were	identified	on	CTA	by	at	least	one	reviewer	as	filling	defects	within	the	left	auricle	(n=6)	and	right	heart	(n=1).	The	highest	sensitivity	for	detection	was	71.4%	(in	continuous	phase)	and	highest	specificity	was	85.7%	(dynamic	study).	The	intra-class	correlation	coefficient	(ICC)	showed	moderate	agreement	for	both	(0.58	for	continuous,	0.64	dynamic).	Smaller	clots,	or	ones	
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with	incomplete	filling	of	the	left	auricle,	were	more	likely	missed	by	reviewers	on	CTA.	Echocardiography	had	low	specificity	(67%)	and	poor	inter-observer	agreement	(ICC	of	.38)	with	multiple	false	positives,	but	had	100%	sensitivity	–	based	on	original	echocardiographic	diagnosis.	CT	provided	multiple	prognostic	indicators	and	comorbidities:	severe	diffuse	idiopathic	pulmonary	fibrosis	(n=1),	asthma	(n=1),	cardiac	enlargement	(n=14),	left	atrial	enlargement	(n=13),	congestive	heart	failure	(5	with	pulmonary	edema	and	8	with	pleural	effusion),	and	an	aortic	thromboembolism.	Findings	from	this	study	suggest	CTA	is	safe,	can	identify	cardiac	clots,	provide	important	prognostic	indicators	(in	patients	with	heart	disease	and	congestive	heart	failure),	and	may	be	used	on	an	emergency	basis	or	when	echocardiography	is	unavailable.	
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CHAPTER	1	INTRODUCTION		 	
	 Arterial	thromboembolism	(ATE)	is	a	devastating	sequela	in	feline	heart	disease	and	continually	an	important	disease	to	study	due	to	its	high	morbidity	and	mortality	rates,	acute	onset,	and	common	presentation	with	no	history	of	heart	disease.1	The	arterial	thrombus	most	commonly	lodges	near	the	aortic	bifurcation	causing	loss	of	pulses,	lower	motor	neuron	signs,	cool	extremities	and	extreme	pain.	These	patients	are	commonly	euthanized	to	prevent	further	distress,	pain	and	because	of	the	poor	prognosis.	Cardiac	disease	is	by	far	the	most	common	origin	of	these	thrombi,	more	specifically	in	left	atrium	and	left	atrial	appendage,	secondary	to	cardiomyopathies.2	Thrombi	form	in	the	left	atrium	and	the	let	atrial	appendage	secondary	to	the	dilation,	blood	stasis,	endothelial	dysfunction	and	platelet	activation.1		
	 Echocardiography	has	long	been	the	reference	standard	for	the	diagnosis	and	assessment	of	cardiac	disease,	including	the	ability	to	identify	and	describe	cardiac	clots.	In	cats,	poor	left	atrial	appendage	contractility	and	maximum	flow	velocities	(<0.20	m/s)	to	the	left	atrium	are	highly	associated	with	spontaneous	echocardiographic	contrast	(SEC)	or	(“smoke”).3	Smoke	is	also	a	highly	accepted	marker	for	a	prothrombotic	state	as	well	as	a	predictor	of	ATE	in	humans	and	cats,4,5	meaning	we	are	able	to	visualize	the	precursors	of	thrombi	formation.	Contrary	to	this,	at	least	one	paper	in	humans,	has	shown	thrombi	formation	with	no	SEC.6	Antiplatelet	therapy	aids	in	preventing	new	or	further	formation	of	thrombi,	and	although	may	prolong	life,	these	patients	remain	at	high	risk	for	ATE.		
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	 Humans	can	suffer	aortic	thromboembolism	or	systemic	embolism	in	a	similar	condition	to	cats,	although	cats	seem	to	be	more	prone	than	humans	or	other	domestic	animals.	In	humans,	approximately	80-90%	are	cardiac	in	origin	with	a	high	association	with	atrial	fibrillation,	cardiomyopathies	and	less	likely	myocardial	infarction.5,7	In	these	patients	angiographic	radiography	or	computed	tomography	is	used	to	evaluate	the	aortic	bifurcation	or	at	the	level	of	patients	signs.	After	a	thromboembolism	is	observed,	cardiac	assessment	via	the	gold	standard	trans-esophageal	echocardiography	(TEE)	is	performed.		
	 More	recently	the	use	of	computed	tomographic	angiography	(CTA)	is	being	used	in	place	of	echocardiography,	as	trans-esophageal	echocardiography	requires	heavy	sedation	and	can	be	painful/mildly	invasive.8	CTA	for	the	detection	of	clots	versus	SEC	in	humans	is	common	now,	where	a	contrast	filling	defect	in	the	left	atrium	is	consistent	with	a	clot.	However	in	one	study	they	found	multiple	filling	defects	(pseudothrombi)	in	the	patients	that	were	in	atrial	fibrillation	and	had	decreased	left	atrial	appendage	emptying.	To	increase	the	specificity	and	positive	predictive	value	to	100%	they	used	a	delayed	arterial	phase	at	1	minute.9	CTA	has	also	shown	to	have	good	correlation	between	other	modalities	(e.g.	MRI,	trans-thoracic	echocardiography.	This	included	global	function	parameters,	morphology,	anatomy	and	demonstrated	good	accuracy	in	humans	and	small	animals	–	even	on	the	16-slice	CT.10,11	A	newer	advancement	and	additional	method	for	obtaining	CT	images	is	using	4D	or	dynamic	(cine-loops),	where	a	specific	region	of	interest	is	selected	dependent	on	the	number	detectors	of	the	CT	scanner	and	coverage.12	The	selected	region	is	scanned	continually	without	moving	in	the	Z-direction,	the	images	are	reconstructed	and	viewed	in	real	time,	essentially	visualizing	the	heart	beating.	There	have	been	few	studies	in	animals	using	4D	and	these	patients	require	heavy	sedation	or	general	anesthesia.	So	the	
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accuracy	of	assessment	of	function	and	clinical	relevance	needs	to	be	taken	into	consideration	since	cardiac	patients	are	poor	anesthetic	candidates	making	imaging	on	an	emergency	basis	difficult.13		
	 We	relate	this	to	our	feline	patients,	who	can	have	limited	or	delayed	diagnostic	imaging	due	to	hemodynamic/cardiopulmonary	instability	(e.g.	dyspnea,	CHF,	ATE)	or	no	access	to	a	cardiologist	(either	on	an	ER	basis	or	within	hospital/region).	Multiple	successful	CTA	studies,	yielding	diagnostic	images,	have	been	performed	in	awake	healthy	and	diseased	cats.14,15	The	first	study	used	a	Plexi-glass	positioning	device	(VetMousetrapTM,	University	of	Illinois,	Urbana,	IL),	which	precludes	the	use	of	anesthesia	while	providing	oxygen,	intravenous	catheter-based	therapy,	a	low	stress	environment	and	ultimately	allowing	earlier	and	more	complete	diagnoses.15	Another	study	performed	CTA	on	awake	healthy	cats	using	a	microdose	(1/10th)	of	the	normal	dose	(2.2ml/kg	or	660	mgI/kg)	of	contrast	agent	and	obtained	images	adequate	for	evaluating	the	cardiac	chambers.16		
	 To	the	author’s	knowledge	there	have	been	no	studies	on	the	comparison	of	smoke	and	clots	in	cats	on	CT	and	echocardiography.	Our	first	objective	is	to	compare	the	ability	of	CTA	to	identify	and	characterize	the	cardiac	clots	from	smoke	in	awake	cats	with	echocardiography	as	our	reference	standard.	We	also	compare	the	continuous	CT	contrast	study	in	previous	studies16	with	dynamic	acquisition	for	clot	identification.	Prognostic	indicators	for	cats	with	hypertrophic	cardiomyopathy	have	been	studied	and	these	include	but	are	not	limited	to:	severe	left	atrial	enlargement,	decrease	left	atrial	and	ventricular	systolic	function,	extreme	left	ventricular	hypertrophy	(>9mm),	congestive	heart	failure,	
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ATE,	gallop,	arrhythmia,	and	regional	hypokinesis.17,18	Our	second	objective	is	to	maximize	the	amount	of	prognostic	indicators	available	to	our	client	and	patient,	who	may	have	to	wait	to	obtain	imaging	(e.g.	radiographs,	echocardiogram).	Our	third	objective	is	to	ensure	this	protocol	is	safe	and	produces	diagnostic	images	in	patients	with	severe	cardiac	disease	and	congestive	heart	failure.		
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CHAPTER	2	LITERATURE	REVIEW		2.1	Heart	disease	in	cats		 The	term	cardiomyopathy	encompasses	multiple	cardiac	diseases	of	the	heart	in	our	feline	patients	and	are	conditions	affecting	the	muscle	(myocardium)	of	the	heart	as	opposed	to	the	valves	such	as	in	mitral	valve	disease.	Cardiomyopathies	are	by	far	the	most	common	cardiac	disease	in	cats	and	hypertrophic	cardiomyopathy	is	the	most	common	subtype.	The	current	list	of	cardiomyopathies	includes	hypertrophic,	restrictive,	dilated,	arrhythmogenic	right	ventricular	and	unclassified.	
	 Hypertrophic	cardiomyopathy	(HCM)	is	characterized	by	increased	cardiac	mass	and	can	include	hypertrophy	of	the	left	ventricle,	by	way	of	interventricular	septum	and/or	free	wall	and	may	be	concentric,	segmental,	or	asymmetric.19	Approximately	two-thirds	of	people	who	develop	HCM	have	an	autosomal	dominant	heritable	defect	(with	incomplete	penetrance	pattern)	in	one	of	11	sarcomeric	proteins.	Hundreds	of	mutations	in	dozes	of	genes	have	been	discovered	in	humans	with	some	families	expressing	novel	mutations.	Familial	HCM	has	been	described	in	cats,	and	is	caused	by	mutations	in	the	myosin	binding	protein	C	in	Maine	coon	cats	and	Ragdoll	cats.20,21	Other	cat	breeds,	such	as	Norwegian	forest	cats,	Persian,	Burmese,	and	Siamese	are	also	suspected	of	having	a	primary	genetic	from	of	HCM.	The	etiology	of	HCM	in	other	cats	remains	unknown	and	may	be	caused	by	unrecognized	mutations.	Diastolic	dysfunction	is	the	main	cause	of	the	secondary	cardiac	abnormalities	such	as	left	atrial	enlargement	due	to	the	increased	filling	pressures.	The	diastolic	dysfunction	is	caused	by	reduced	ventricular	relaxation	and	may	be	from	the	
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underlying	hypertrophy,	secondary	interstitial	fibrosis,	loss	of	myocardial	architecture	or	a	combination	of	all	of	them.19		
	 Restrictive	cardiomyopathy	is	an	increase	in	the	stiffness	of	the	myocardium	and	is	the	second	most	common	type	of	cardiomyopathy	with	two	major	forms	(myocardial	and	endomyocardial).19	Like	HCM,	this	type	causes	restrictive	filling	of	the	left	ventricle	usually	resulting	in	severe	left	atrial	or	bi-atrial	enlargement.	The	endomyocardial	form	can	present	with	extensive	secondary	fibrotic	lesions,	even	bridging	the	lumen	of	the	ventricle.19	
	 Dilated	cardiomyopathy	(DCM)	is	an	adult	onset	primary	myocardial	disease	characterized	by	dilation	of	the	left	ventricular	lumen	and	decreased	systolic	myocardial	function.		DCM	used	to	be	the	most	common	form	of	feline	myocardial	disease	until	it	was	determined	that	many	cats	suffered	from	taurine	deficiency	due	to	insufficient	levels	of	taurine	in	commercial	pet	foods.22	Grossly	there	is	dilation	of	the	left	ventricle,	poor	contractility,	as	well	as	right	and/or	left	atrial	enlargement.	Now	this	disease	is	far	less	common	and	may	be	secondary	to	another	end-stage	cardiac	disease	such	as	HCM,	valvular	disease,	sustained	tachycardia,	unrecognized	episodes	of	toxicity,	viral	infection,	or	ischemic	myocardial	disease.19		
	 Arrhythmogenic	right	ventricular	cardiomyopathy	(ARVC)	is	an	adult	onset	primary	myocardial	disease	characterized	by	fibrofatty	infiltration	of	the	right	ventricular	myocardium.23	ARVC	is	thought	of	as	a	right-sided	disease	with	enlargement	of	the	right	ventricle,	but	in	some	cases	the	disease	included	the	left	ventricle	and	interventricular	septum.	The	right	ventricle	can	often	become	markedly	enlarged	and	thin	with	poor	
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contractility.	These	cats	may	present	with	arrhythmias,	right	sided	heart	failure,	and	conduction	abnormalities.19		
	 The	last	cardiomyopathy	is	unclassified,	meaning	that	the	abnormalities	cannot	be	classified	into	one	of	the	aforementioned	groups.	Similar	to	DCM,	this	condition	may	represent	an	early	or	end-stage	of	one	of	the	other	conditions.		
2.2	Clot	development	in	cat	hearts	
	 All	of	these	cardiomyopathies	can	lead	to	left	atrial	enlargement,	and	as	stated	above,	HCM	is	the	most	common	cardiac	disease	in	cats	and	it	is	common	for	cats	with	HCM	to	develop	left	atrial	enlargement.	Left	atrial	enlargement	is	the	most	important	risk	factor	for	the	development	of	the	left	atrial	thrombi.	But	it	is	not	the	size	alone	that	creates	an	environment	conducive	of	thrombi	formation,	as	thrombogenesis	is	multifactorial.	In	fact,	many	cats	with	enlarged	atria	do	not	develop	a	thrombus	further	confirming	the	complexity	of	this	process.		
	 The	enlargement	of	the	left	atrium	and	the	secondary	poor	function	is	known	to	cause	two	conditions	(endothelial	dysfunction	and	blood	stasis)	that	predispose	the	left	atrium	and	the	left	auricle	to	develop	clots.24	Results	regarding	hypercoagulability	in	cats	with	heart	disease	have	been	variable;	however,	a	hypercoagulable	environment	is	present	in	some	cats.	These	are	thought	of	as	interconnected,	creating	a	cumulative	risk	of	thrombus	(clot)	formation.	This	principle	is	known	as	Virchow’s	triad,	where	each	of	the	three	arms	of	the	triad	contributes	to	the	formation	of	the	clot.		
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	 Within	the	normal	heart	there	is	normal	turnover	of	thrombogenesis	and	thrombolysis,	however	these	three	arms	of	the	triad	all	contribute	to	clot	formation.	Adhesion	of	platelets	to	subendothelial	collagen	secondary	to	endothelial	injury	is	the	primary	initiating	factor	for	hemostasis.24	The	platelets	aggregate	at	this	site	while	more	platelets	are	activated	to	allow	healing	of	the	endothelial	surface.	Then	secondary	hemostasis	is	initiated	whereby	circulating	plasma	coagulation	factors	contribute	to	assist	in	healing	of	the	hemostatic	plug.	In	a	normal	heart,	profibrinolytic	mechanisms	break	down	the	plug	once	the	endothelium	is	healed	to	prevent	exuberant	clot	formation.	In	cats	with	an	enlarged	left	atrium	and	poor	auricular	function,	the	ability	to	empty	the	left	auricle	and	left	atrium	is	reduced	creating	blood	pooling	(or	stasis).	This	decreased	ability	of	the	left	auricle	to	rid	itself	of	the	precursors	to	clot	formation	(or	the	aggregates	of	platelets	and	clotting	factors)	causes	further	build	up	and	thrombus	formation	ensues.		
	 A	hypercoagulable	state	is	the	third	arm	of	Virchow’s	triad	and	may	be	a	local	process,	from	the	localized	stretching	and	disease	of	the	atrium,	or	systemic.	Examples	of	systemic	hypercoagulability	and	thrombus	formation	include	platelet	hypersensitivity,	decreased	antithrombin	and	protein	C	activities,	and	increases	in	factor	VIII	and	fibrinogen.24	Identifying	hypercoagulability	in	patients	is	difficult	by	using	prothrombin	time	(PT)	and	activated	partial	thromboplastin	time	(aPTT)	and	has	been	found	to	be	unreliable	and	not	clinically	useful.	Newer	analyses	are	becoming	more	useful	to	identify	hypercoagulable	tendencies	in	cats	and	include	Viscoelastic	coagulation	monitors	(thromboelastography,	sonoclot,	thromboelastometry).24,25	Use	of	these	tests	in	felines	has	not	been	implemented	as	much	as	in	dogs,	and	may	be	due	to	the	likelihood	of	the	activation	of	coagulation	factors	during	sample	collection	and	because	they	may	not	
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accurately	identify	hypercoagulable	patients	as	well	as	hypocoagulable	ones	because	a	standard	protocol	has	not	been	established.24		
2.3	Feline	arterial	thromboembolism	
	 The	formation	of	the	thrombus	(clot)	in	the	heart	is	critical	to	evaluate	for,	identify	and	prevent,	because	it	is	the	precursor	for	feline	arterial	thromboembolism.	However,	cardiac	disease	is	not	present	in	every	cat	with	a	thrombus.	Thromboembolism	occurs	when	a	thrombus	that	is	most	of	the	time	adhered	to	the	wall	of	the	left	auricle,	dislodges	and	enters	systemic	circulation.	The	thrombus	will	inevitably	obstruct	a	vessel	and	cause	infarction	or	at	least	partial	occlusion	of	a	vessel	or	arterial	bed.	The	most	common	site	in	the	cat	is	the	aortic	bifurcation	(79-85%)	and	is	termed	saddle	thrombus,	feline	arterial	thromboembolism	(FATE)	or	systemic	arterial	thromboembolism	(SATE)24.	This	is	mostly	bilateral	but	can	be	unilateral.		These	cats	usually	present	acutely	with	paresis	or	paralysis	of	the	pelvic	limbs	and	can	have	absent	segmental	reflexes,	cold	and	firm	musculature,	absent	femoral	pulses,	cyanotic	nail	beds,	and	are	usually	very	painful.24	The	theory	behind	the	absent	segmental	spinal	reflexes	secondary	to	the	arterial	occlusion	is	an	ischemic	neuromyopathy	from	a	release	of	serotonin	and	possibly	thromboxane	A2.	These	are	released	from	the	platelets	from	induced	vasoconstriction	of	the	collateral	vessels	of	the	vertebral	system	and	epaxial	muscles.24,26	Also	a	cause	of	the	extreme	pain	of	these	patients	may	be	due	to	activated	platelets	that	release	serotonin	which	has	been	shown	to	stimulate	nociceptive	sympathetic	afferent	fibers.24,27	The	clots	can	go	to	other	vascular	beds	such	as	the	thoracic	limb,	which	is	the	second	most	common	site,	as	well	as	cerebral,	renal	and	mesenteric	
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	 This	is	a	condition	that	is	associated	with	high	mortality	and	morbidity.	Most	clinical	studies	have	reported	incidences	of	FATE	ranging	from	12-28%	of	cats	with	heart	disease.	Specifically,	reported	percentages	of	cats	that	develop	ATE	with	the	various	cardiomyopathies	ranges	from:	56%	with	restrictive	cardiomyopathy,	12-17%	with	hypertrophic	cardiomyopathy,28	18%	with	dilated	cardiomyopathy.29	In	the	general	feline	population,	the	reported	prevalence	has	ranged	from	1	in	142	to	1	in	175	cats	evaluated.29	The	patients	are	often	in	distress	and	the	clients	(also	from	personal	experience)	may	be	completely	unaware	of	what	is	occurring	to	their	pet.	Most	cats	presented	for	FATE	have	underlying	heart	disease;	however,	clinical	manifestations	are	often	absent	prior	to	the	event.	Heart	disease	may	go	unnoticed	especially	in	cats	for	many	reasons	and	the	diagnosis	of	heart	disease	will	be	explained	in	detail	later.	One	of	the	reasons	is	the	reclusive	nature	of	the	cat	to	hide	or	an	outdoor	cat	that	comes	around	intermittently	and	another	is	that	physical	exam	findings,	such	as	heart	murmurs,	gallop	sounds,	and	arrhythmias	can	be	absent	in	cats	with	underlying	cardiac	disease.	Unfortunately	even	with	acute	treatment	for	FATE,	the	prognosis	is	generally	poor,	owners	will	commonly	elect	euthanasia	and	clinicians	will	offer	this	as	an	option.	These	reasons	show	how	devastating	this	disease	is	and	how	important	detecting	and	preventing	it	are.	The	first	24	hours	are	also	the	most	distressing	and	painful	and	many	owners	will	not	want	to	pursue	treatment	to	prevent	any	further	pain	or	discomfort	to	their	pet.	The	short-term	prognosis	for	FATE	depends	largely	on	the	nature	and	responsiveness	of	the	underlying	heart	disease	and	the	owner’s	willingness	to	treat.	Survival	to	discharge,	in	cats	with	FATE	and	owners	willing	to	treat,	has	been	reported	to	be	up	to	45%.24	Multiple	risk	factors	have	been	associated	with	decreased	survival	and	include	hypothermia,	reduced	heart	rate,	and	absence	of	motor	
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function	in	the	affected	limbs.24	The	echocardiographic	changes	that	increase	the	risk	of	morbidity	and	mortality	will	be	discussed	later.	Since	treating	the	primary	cardiac	condition	is	not	possible	with	hypertrophic	cardiomyopathy	and	the	other	cardiomyopathies	(excluding	taurine-deficiencies),	prevention	of	clot	formation	is	the	best	option.	If	the	patient/owner	elect	treatment	due	to	an	arterial	thromboembolism	diagnosis,	then	immediate	supportive	care,	antithrombotic	treatment,	and	antiplatelet	therapy	is	required.	Regardless	of	decision,	pain	control	should	be	immediately	administered	and	any	patients	with	concurrent	CHF	(including	pulmonary	edema	and	pleural	effusion)	should	be	treated	appropriately	as	well.	Surgery	is	not	recommended	due	high	risk	of	death	and	thrombus	excision	is	very	difficult.30	Also	rapid	reperfusion	injury	after	ischemic	events	can	be	life	threatening.	Reperfusion	injury	is	a	build	up	of	metabolites	including	potassium	and	free	oxygen	radicals	that	are	released	into	systemic	circulation	and	can	cause	arrhythmias,	acid-base	disturbances,	renal	dysfunction,	and	death.30		
2.4	Treatment	of	feline	arterial	thromboembolism	
	 At	this	time	we	do	not	have	safe	thrombolytic	medications	or	treatments	that	will	lyse	the	existing	clots	in	cats.	As	such	treatment	is	geared	toward	preventing	further	accumulation	of	these	clots	and	allowing	the	body	to	naturally	break	them	down.	There	have	been	multiple	attempts	to	use	thrombolytic	therapies.	One	study	used	tissue	plasminogen	activator	in	11	cats	but	adverse	effects	were	seen	in	all	cats	including	azotemia,	neurological	disorders,	arrhythmias,	etc.	despite	seeing	signs	compatible	with	thrombolysis	in	6/9	cats.31	Another	study	used	intra-arterial	urokinase	administration	after	failure	of	standard	treatments	and	motor	function	of	both	hind	limbs	with	no	
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complications	noted.32	However	this	is	an	invasion	procedure,	requiring	general	anesthesia	and	was	only	tested	in	one	patient,	so	further	investigation	is	required.	The	survival	to	hospital	discharge	was	not	superior	to	other	therapies	with	thrombolytic	treatments.		
	 Since	these	treatments	have	not	become	commonly	performed	a	general	consensus	for	treatment	will	now	be	described.	Fluid	therapy	is	usually	avoided	but	may	be	warranted	in	azotemic	patients,	although	very	cautiously.	Once	pain	control,	and	CHF	is	either	evaluated	for,	or	treated,	then	antithrombotic	therapy	and	antiplatelet	therapy	is	initiated.	Since	hypothermia	is	a	risk	of	morbidity	and	mortality,	keeping	the	patient	in	a	comfortable,	warm	environment	is	recommended	as	well	as	passive	manipulation	and	physiotherapy.30	Decreased	pain,	increased	pulse	strength,	and	motor	function	are	indications	that	limb	circulation	is	improving.	However	signs	of	reperfusion	injury	and	necrosis	may	occur	rapidly	so	close	monitoring	within	the	hospital	is	recommended.	After	a	couple	days	of	close	monitoring	these	patient	with	improving	signs	may	be	released	to	their	owners	to	go	home	–	with	close	monitoring	required.		
	 There	are	two	main	categories	of	antithrombotic	drugs	for	cats,	similar	to	humans,	and	they	are	antiplatelet	agents	and	anticoagulants.	The	two	most	common	antiplatelet	drugs	used	in	cats	are	aspirin	and	clopidogrel	(aspirin	more	commonly	than	clopidogrel).	Aspirin	prevents	the	formation	of	thromboxane	A2	by	irreversibly	acetylating	platelet	cyclooxygenase	as	well	as	within	the	endothelial	cells,	preventing	aggregation	of	platelets	and	causes	vasodilatory	effects.24	A	newer	study	showed	that	aspirin	was	inferior	to	clopidogrel	for	secondary	prevention	of	cardiogenic	embolism	in	cats.33	Clopidogrel	is	a	second-generation	theriopyridine	that	induces	irreversible	and	specific	antagonism	of	the	
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P2Y12	receptor	and	the	subsequent	ADP-mediated	activation	of	the	glycoprotein	GPIIb/IIIa	complex	of	the	platelet	membrane	and	has	more	potent	inhibitory	effect	on	platelets	than	aspirin.24	It	also	decreases	the	release	of	aggregating	and	vasoconstrictive	properties	of	serotonin	and	ADP.	Clopidogrel	was	superior	to	aspirin	in	a	multi-institutional	study	evaluating	the	secondary	prevention	of	FATE.	Cats	receiving	clopidogrel	had	a	recurrence	rate	of	cardiogenic	embolism	of	49%	versus	75%	for	aspirin	and	1	year	recurrence	rate	of	36%	versus	64%	for	aspirin.	Additionally	the	median	time	to	recurrence	was	significantly	longer	in	cats	receiving	clopidogrel	(146	days)	compared	with	aspirin	(84	days).24,34	So	clopidogrel	is	the	likely	choice	going	forward	in	the	feline	patients	that	are	at	risk	for	developing	cardiac	clots.		
	 The	anticoagulant	drugs	that	may	be	used	are	Warfarin	and	low	molecular-weight	heparins	that	work	by	inhibiting	the	coagulation	cascade	and	interfering	with	the	coagulation	factors	preventing	clotting	(or	secondary	coagulation).	Although	not	used	for	primary	or	secondary	prevention	in	cats,	they	are	the	primary	choice	in	humans.24	Warfarin	prevents	the	formation	of	vitamin	K-dependent	coagulation	factors	II,	VII,	IX,	and	X	and	proteins	C	and	S,	which	are	anticoagulant	proteins.	Bleeding	is	the	major	and	minor	complication	from	this	medication,	it	has	a	variable	clinical	response	and	requires	routine	frequent	monitoring,	limiting	its	use.24	Unfractionated	and	low	molecular-weight	heparins	prevent	the	activation	of	coagulation	factor	X.24	These	medications	have	lower	bleeding	complication	rates	compared	to	Warfarin,	same	as	in	humans,	and	may	be	used	more	widely	than	Warfarin.	Newer	anticoagulants	called	factor	Xa	inhibitors	in	humans	are	being	developed	and	very	little	data	or	use	has	been	done	in	cats.	One	medication	(rivaoxaban)	has	shown	to	have	predictable	and	repeatable	anticoagulant	effect	when	administered	in	
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cats	and	one	author	thinks	that	they	will	have	an	impact	on	thrombus	prophylaxis	over	the	next	5-10	years.24	Since	our	ability	to	remove	or	break	down	these	clots	is	almost	nonexistent,	our	best	treatment	at	this	point	is	prevention.	So	far	my	discussion	has	shown	prevention	by	prophylaxis	of	the	clots,	but	the	diagnosis	of	heart	disease	and	these	clots	is	an	integral	part	of	the	treatment	and	prevention.		
2.5	Diagnosing	heart	disease	in	cats	
	 In	cats	the	reliability	of	a	murmur	to	detect	heart	disease	is	low,	meaning	turbulent	blood	flow	can	be	a	benign	process	in	the	cat,	compared	to	dogs	where	usually	a	murmur	is	an	indication	of	structural	heart	disease.		In	one	study	of	1007	cats,	heart	murmurs	were	present	in	40%	of	apparently	healthy	cats,	and	70%	of	those	murmurs	were	considered	to	be	functional	(no	structural	heart	disease),	resulting	in	a	positive	predictor	value	of	17-43%	for	the	presence	of	a	murmur	in	an	apparently	healthy	cat	to	detect	structural	heart	disesase.35	The	most	common	heart	disease	found	in	this	study	was	HCM	(left	ventricular	thickness	of	>6mm)	with	a	prevalence	of	14.7%.	Essentially	this	means	that	many,	apparently	healthy	cats	have	functional	murmurs	unrelated	to	cardiac	disease.	Also,	feline	murmurs	can	be	more	difficult	to	auscultate	than	dogs.		
	 Radiographs	using	subjective	and	objective	assessments	can	usually	make	the	diagnosis	of	heart	disease	in	small	animals	initially.	In	cats	the	specific	regions	of	the	heart	including	the	left	atrium	and	main	pulmonary	artery	can	be	more	difficult	to	assess	for	enlargement	on	radiographs	so	overall	size	is	more	important.	For	cats	the	cardiac	silhouette	should	be	within	2-2.5	intercostal	spaces	on	the	lateral	projection	(or	between	the	fifth	rib	and	the	7th	rib.	The	vertebral	heart	score	should	be	7.5	+/-	0.3	on	the	lateral	
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view	and	3.4	+/-	0.25	on	DV/VD	image.36	As	mentioned	before,	overall	size	should	alert	clinician	of	heart	disease	rather	than	specific	chamber	enlargement	and	unlike	dogs,	cats	could	be	in	heart	failure	with	a	normal	sized	left	atrium	on	radiographs.37	When	left	atrial	enlargement	is	seen	on	the	radiographs	in	a	cat,	the	left	atrium	is	moderately	to	severely	enlarged.	However	if	the	left	atrium	is	normal,	the	patient	could	still	be	in	heart	failure,	given	that	the	lung	changes	are	consistent	with	pulmonary	edema.37	The	pulmonary	vessels	in	the	same	study	by	Schober	et.	al.	(2014),	were	not	an	indicator	for	heart	failure	as	well.	In	fact,	the	pulmonary	arteries	were	more	likely	to	be	enlarged	than	the	pulmonary	veins,	which	is	inconsistent	with	canine	left	heart	failure.		
	 Another	caveat	to	feline	pulmonary	edema	is	the	similarities	to	other	common	pulmonary	diseases.	Consistent	with	other	research,	text	books,	and	the	author’s	experience,	feline	pulmonary	edema	can	appear	radiographically	similar	to	other	conditions,	such	as	feline	lower	airway	disease	(e.g.	asthma	or	chronic	bronchitis),	atypical	pneumonia	(e.g.	Mycoplasma),	and	neoplasia	(e.g.	carcinoma).	The	classic	distribution	of	feline	pulmonary	edema	is	multifocal	patchy	alveolar	or	interstitial	opacities,	or	it	can	display	similar	characteristics	to	canine	congestive	heart	failure	(CHF).	Also	feline	CHF	can	be	solely	or	largely	pleural	effusion.	This	causes	two	major	drawbacks	when	evaluating	for	heart	disease	or	failure	in	the	cat.	The	first	is	that	pleural	effusion	can	cause	border	effacement	of	the	cardiac	size	obscuring	assessment	of	the	cardiac	silhouette.	Pleural	effusion	differentials	for	a	cat	are	many	but	the	more	common	causes	are	secondary	to	right	or	left	heart	failure,	(although	right	heart	failure	is	much	less	common	than	right),36	pyothorax,	chylothorax	(which	may	be	associated	with	heart	failure),	feline	infectious	peritonitis	(FIP),	neoplastic,	etc.	Secondly,	pleural	effusion	also	causes	atelectasis	of	the	
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lung	lobes	creating	an	interstitial	to	alveolar	pattern,	which	can	be	difficult	to	interpret	from	pulmonary	edema.	Another	characteristic	of	pulmonary	edema	is	cats	is	the	appearance	of	bronchial	thickening	that	may	be	misinterpreted	as	primary	bronchial	disease,	which	is	a	very	common	condition	in	cats.	In	reality	this	is	peribronchial	cuffing	(fluid	leaking	from	the	vessels	into	the	surrounding	interstitium	or	primary	pulmonary	disease)	mimicking	thickening	of	the	walls	of	the	bronchus.38	So	all	in	all,	cat	thoracic	radiographs	can	be	difficult	to	interpret,	may	not	always	display	typical	evidence	of	heart	disease,	and	may	be	misinterpreted	as	more	benign	or	malignant	disease.	This	shows	how	important	pursuing	echocardiography	or	advanced	imaging	can	be	when	a	feline	patient	is	displaying	signs	of	congestive	heart	failure,	because	the	radiographic	findings	can	mimic	other	diseases	and	may	not	exhibit	common	identifiable	signs	of	congestive	heart	failure.	However,	congestive	heart	failure	in	cats	is	very	common	for	cats	presenting	for	respiratory	distress,	so	treating	empirically	for	heart	failure	as	a	first	line	can	be	life	saving.			
	 Radiography	may	show	signs	compatible	with	left	heart	failure,	however	specific	structural	heart	disease,	function,	as	well	as	clots	cannot	be	identified	or	measured.	Echocardiography	is	the	gold	standard	for	evaluating	the	structure	and	function	of	the	heart	in	cats.	As	explained	much	earlier	there	are	multiple	cardiomyopathies	in	cats,	with	hypertrophic	cardiomyopathy	being	the	most	common.	Left	atrial	and	left	auricular	(auricle)	enlargement	is	the	most	common	sequela	and	the	region	of	the	origination	of	the	clots.	On	echocardiogram,	multiple	factors	go	into	a	diagnosis	of	cardiomyopathy	and	the	differences	between	these	will	further	classify	them.	A	left	ventricular	wall	thickness	in	diastole	of	≥6mm	is	the	most	common	reference	for	diagnosis	of	HCM	and	that	is	either	focal	or	diffuse	and	asymmetric	or	symmetric	in	appearance.36	Other	less	common	
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conditions	must	be	ruled	that	can	cause	similar	left	ventricular	hypertrophy	and	these	include	systemic	hypertension,	hyperthyroidism,	acromegaly,	lymphoma,	aortic	stenosis	and	muscular	dystrophy.	Other	structural	changes	that	can	be	seen	with	HCM	are	smaller	or	larger	left	ventricular	volume,	hypertrophied	papillary	muscles,	dilated	left	atrium	and	left	auricle.	
	 The	left	atrial	and	auricular	dilation,	which	a	very	common	sequela	due	to	increased	atrial	pressures	is	most	important	for	this	study	as	it	is	the	site	of	clot	formation.	A	newer	study	showed	that	reduced	fractional	shortening	of	the	left	atrium	was	associated	with	the	cat	dying	from	an	ATE	rather	than	congestive	heart	failure.33	This	makes	sense	because	in	another	paper	a	left	auricular	outflow	velocity	of	less	than	0.2m/sec	indicates	the	patient	is	at	risk	for	spontaneous	echocardiographic	contrast	(SEC)	which	is	considered	a	marker	of	a	prothrombotic	state	and	a	precursor	to	development	of	clots.4	This	SEC	or	“smoke”	is	seen	as	increased	backscatter	or	echogenicity	of	the	red	blood	cell	aggregates	that	form	due	to	the	low	velocity	and	causes	that	were	discussed	earlier.	Also,	cats	with	over	0.25m/sec	left	auricular	outflow	velocity	are	considered	less	at	risk	of	developing	a	thrombus.	Other	potential	risk	factors	of	a	prothrombotic	state	in	that	study	were	the	severity	of	left	atrial	enlargement,	presence	of	congestive	heart	failure,	and	severity	of	left	ventricular	diastolic	dysfunction.	Unlike	in	humans	this	study	did	not	find	atrial	fibrillation	as	a	risk	factor	for	SEC,	although	all	the	cats	in	the	study	had	a	low	left	auricular	outflow	velocities	of	under	0.23m/s,	indicating	poor	flow	and	a	high	risk	for	clot	formation.	When	clots	form	they	usually	will	be	confined	to	the	left	auricle	(commonly	adhered	to	the	wall)	and	appear	as	an	irregular	to	smoothly	marginated	echogenic	structure	of	any	shape.		
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2.6	Human	thromboembolism	and	diagnosis	
	 In	humans	left	atrial	thrombi	occur	most	commonly	secondary	to	atrial	fibrillation	and	the	causes	are	the	same	that	affect	the	feline	patients	(i.e.	Virchow’s	triad)	that	was	previously	discussed.	However,	the	main	difference	between	the	feline	and	human	causes	are	that	cats	almost	always	have	structural	heart	disease	(e.g.	cardiomyopathy),	as	opposed	to	humans,	where	the	electrical	disturbance	of	atrial	fibrillation	is	the	cause	in	~60%	of	all	cardioembolic	strokes.39,40	Similar	to	feline	patients,	the	decreased	velocity	and	function	of	the	left	atrium	and	left	auricle	secondary	to	reduced	contractility	in	patients	with	atrial	fibrillation	is	the	cause.	Transesophageal	echocardiography	(TEE)	is	the	gold	standard	in	human	medicine	to	image	the	left	auricle	due	to	its	capability	to	visualize	all	parts	of	the	appendage	and	is	considered	superior	to	transthoracic	ultrasound	(TTE)	for	ruling	out	left	atrial	and	left	auricular	thrombi.39	The	thrombi	and	SEC	are	similar	in	appearance	to	the	feline	patients	and	also	form	within	the	left	auricle	more	commonly	as	well.	On	echocardiography	thrombi	are	typically	defined	as	a	well-defined	echogenic	mass	with	alternate	echotexture	than	that	of	the	left	atrial	wall	as	well	as	a	uniform	consistency	that	is	a	separate	entity	from	the	pectinate	muscles	of	the	left	auricle.34	Descriptions	of	the	SEC	are	usually	mild,	moderate	or	severe	in	echogenicity.	Due	to	the	requirements	of	heavy	sedation,	and	contraindications	such	as	potential	esophageal	pathology,	patients	may	not	be	able	to	have	TEE	performed	and	less	invasive	procedures	may	be	required.	In	one	study,	they	describe	the	TEE	procedure	using	topical	local	anesthetic	(Lidocaine)	in	the	hypopharynx	with	intravenous	(IV)	benzodiazepine	sedation.6	TEE	is	also	more	time	consuming	than	TTE.		
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	 More	recently	contrast	enhanced	multidetector	computed	tomography	(CE-MDCT)	has	been	proposed	as	an	alternative	to	evaluating	the	heart	in	patients	that	are	not	good	candidates	for	TEE.	A	paper	including	a	responding	letter	to	the	editor	about	said	paper	discussed	the	applicability	of	measuring	pre	and	post	contrast	Hounsfield	units	(HU)	of	the	thrombi	in	assessment	of	acute	and	chronic	pulmonary	thromboembolisms.		There	is	only	discussion	and	no	consensus	about	the	accuracy	of	measuring	the	thrombi	attenuation	because	there	is	evidence	for	acute	clots	to	be	isoattenuating	on	pre-contrast	as	the	contents	are	very	similar	to	the	surrounding	blood.41	This	means	contrast	is	required	to	identify	the	clots.	However,	the	sensitivity	and	specificity	for	identification	of	the	thrombi	has	a	wide	range	over	multiple	research	papers,	until	more	recently.	The	wide	range	of	sensitivity,	specificity,	positive	predictor	value	(PPV)	and	negative	predictor	values	(NPV),	are	in	large	part,	due	to	the	poor	contractility,	flow	and	mixing	of	the	contrast	within	the	LAA	that	can	result	in	a	pseudothrombus.	A	high	number	of	patients	will	be	in	active	atrial	fibrillation	during	the	exam,	so	these	pseudothrombi	are	very	common	in	patients	on	CT	and	should	not	be	confused	as	true	thrombi.42	Left	auricular	thrombi	and	pseudothrombi	are	very	similar	in	appearance	on	CT,	creating	a	filling	defect	(or	noncontrast	enhancing	region)	within	the	contrast	filled	left	atrium	or	left	auricle.	One	paper	showed	high	sensitivity	and	specificity	(100%	and	92%	respectively)	to	identify	an	abnormal	left	auricle	using	non-gated	CTA	while	acquiring	images	of	the	heart	all	at	once	(i.e.	using	dynamic	imaging	and	using	all	64	detectors).43	They	also	stated	that	they	were	not	as	accurate	to	discriminate	SEC	from	thrombus,	but	a	normal	CT	was	very	specific	for	a	normal	left	atrium	and	left	auricle.	This	paper	was	later	refuted,	saying	the	positive	predictor	values	for	identification	of	true	thrombus	were	so	poor	that	cardiac	CT	should	not	replace	TEE	and	
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further	research	should	be	performed	because	that	means	many	of	the	positive	CT	cases	did	not	have	a	thrombus.8	Another	study	showed	that	performing	a	delayed	(1	minute)	single	phase	study	of	the	heart	again	without	a	second	dose	of	contrast	increases	the	sensitivity,	specificity,	PPV	and	NPV	all	to	100%.9	The	study	demonstrated	that	the	filling	defect	was	a	pseudothrombus	if	the	left	auricle	showed	homogenous	contrast	enhancement	similar	to	the	remainder	of	the	left	atrium	on	the	delayed	images.	Although,	this	paper	did	not	cite	the	other	paper	mentioned	before.	In	another	study	they	found	that	quantifying	the	HU	of	the	left	auricle	was	inaccurate	(sensitivity	of	85%,	specificity	of	94%),	and	that	subjective	assessment	(or	visual	analysis)	was	better	(sensitivity	of	96%,	specificity	of	100%).44	But	from	the	author’s	perspective,	this	is	dependent	on	dose	and	image	acquisition	technique,	and	may	not	be	useful	to	compare	from	one	case	to	another.	This	is	especially	true	as	it	applies	to	feline	patients	because	these	human	papers	now	use	electrocardiographic	(ECG)	gating	to	remove	motion	and	artifact	to	obtain	images	with	very	good	spatial	and	temporal	resolution.	The	same	study	used	a	slightly	different	technique	and	performed	only	a	scan	of	the	second	dose	of	contrast	(or	dual	enhancement	with	single	delayed	phase)	at	180	seconds	following	the	first	IV	contrast	dose.	The	objective	was	to	evaluate	for	the	thrombi	only	on	the	second	contrast	dose	since	that	was	the	phase	that	distinguished	between	thrombi	and	pseudothrombi	on	the	previous	papers.		The	thought	is	that	there	would	be	more	mixing	of	the	contrast	within	the	left	auricle	and	thus	higher	attenuation	values	for	SEC	and	lower	for	the	thrombi.	A	follow	up	study	from	the	same	authors	of	the	previous	study,	used	ECG	prospective	gating	to	reduce	the	radiation	doses	to	the	patient	and	acquire	better	images.	They	demonstrated	a	sensitivity,	specificity,	PPV,	and	NPV	of	89%,	100%,	100%,	99%	respectively	for	identifying	and	ruling	
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in	or	out	LAA	thrombi.44	This	sensitivity	is	lower	than	the	other	paper	but	also	described	that	the	HU	were	significantly	different	between	SEC	and	thrombus	(lower	for	thrombi	than	for	SEC),	which	may	be	beneficial	to	measure.	So	there	is	quite	the	discrepancy	for	whether	quantitative	or	subjective	analysis	is	better,	but	the	ability	to	detect	thrombi	and	differentiate	them	from	circulatory	stasis	–	or	patients	in	atrial	fibrillation	–	is	improving.	A	very	recent	paper,	argues	that	their	high	NPV	of	95.2%	demonstrates	that	not	seeing	a	thrombus	or	circulatory	stasis	basically	rules	out	a	thrombus.39	Also	quantitative	inspection	did	not	increase	any	of	the	parameters	to	identify	nor	rule	out	a	thrombus.	This	means,	when	a	thrombus	is	not	visualized	subjectively,	measuring	the	HU’s	will	not	aid	in	predicting	a	negative	result.	Most	importantly,	they	claim	that	in	patients	with	a	potential	risk	that	precludes	TEE,	MDCT	using	retrospective	ECG	gating,	can	replace	TEE	for	ruling	out	LAA	thrombi.39	However	in	contrast	to	other	papers,	the	patients	with	pseudothrombi	and/or	atrial	fibrillation,	the	sensitivity	(81.5%)	and	PPV	(87.5%)	were	less	accurate	than	other	reports,	indicating	those	patients	may	require	further	investigation.		
	 Dynamic	CT	was	briefly	mentioned	in	the	previous	paragraphs.	Dynamic	CT	is	the	use	of	CT	in	real	time,	allowing	evaluation	of	changes	within	attenuation	(density)	within	a	specific	region	over	time.	A	specific	slice	or	region	(organ,	lesion)	is	scanned	in	concert	with	contrast	administration.	The	changes	and	characteristics	of	the	region	may	represent	physiologic	processes	(heart	beating)	or	pathological	(portosystemic	shunts,	tissue	perfusion).45	As	described	previously,	non-gated	contrast	enhanced	dynamic	CT	has	been	used	to	evaluate	for	cardiac	clots	in	humans	but	has	not	become	widely	used	because	the	inaccuracy	of	delineating	thrombi	from	SEC.	Dynamic	ECG-gated	contrast	enhanced	CT	has	been	used	in	numerous	other	applications	in	humans,	including	but	not	limited	to	
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pulmonary	nodule	differentiation	of	malignant	versus	benign,	cardiac	valve	and	ventricular	function,	cardiac	perfusion.12,46–51	However	the	radiation	dose	is	much	higher	than	non-gated	and	is	a	concern	in	humans.8	In	veterinary	medicine,	this	is	of	less	concern	to	our	patients	and	has	been	used	in	multiple	scenarios	including	but	not	limited	to:	identifying	small	pituitary	masses,	contrast	bolus	techniques	in	many	diseases,	liver	nodule	and	mass	differentiation,	hepatic	perfusion,	tracheal	collapse,	urinary	tract	conditions	(such	as	glomerular	filtration	rate,	ectopic	ureters),	pancreas	disease	(perfusion	and	mass	differentiation).40,47–52	Dynamic	CT	is	limited	by	the	amount	of	detectors.	For	instance	our	CT	scanner	is	a	16-slice	scanner	meaning	it	has	16	detectors	aligned	on	the	Z-axis	of	the	patient	that	can	simultaneously	and	continuously	acquire	images	without	moving	the	patient	(or	organ).	The	slice	thickness	also	affects	the	coverage	or	length	of	target	organ	imaged	because	choosing	a	smaller	slice	thickness	will	use	16	smaller	detectors,	thus	a	smaller	coverage	and	larger	slice	thickness	will	use	16	larger	detectors,	thus	larger	coverage.	So	if	your	target	organ	(or	lesion)	is	larger	than	the	coverage,	than	that	section	will	not	be	scanned.	For	example,	our	16	slice	machine	will	use	1.25mm	detectors	over	16	slices,	so	16	x	1.25mm	=	20mm.	If	we	were	to	obtain	thinner	slices	at	0.625mm	over	16	slices	(detectors)	that	would	give	us	coverage	of	10mm.	In	our	study	we	will	be	looking	at	the	left	auricle	and	part	of	the	left	atrium.	Although,	these	appendages	are	pathologically	enlarged	in	our	patients,	we	hope	that	this	will	still	suffice,	even	though	identifying	if	dynamic	studies	will	produce	adequate	images	is	part	of	the	study.	
2.7	Transesophageal	echocardiography	in	cats	
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	 In	the	feline	patients,	TTE	is	the	gold	standard	and	TEE	is	not	usually	performed	due	to	limited	applicability.	TEE	in	feline	patients	requires	general	anesthesia	and	arguably	patients	should	be	good	anesthesia	candidates	(i.e.	hemodynamically	stable).	Our	feline	patients	are	usually	not	stable	or	have	structural	heart	disease	and	are	at	risk	for	anesthetic	related	death.	Secondly,	the	transesophageal	transducers	must	be	pediatric	due	to	the	small	size	of	the	feline	patients	and	may	be	cost	prohibitive.58	Furthermore	one	study	showed	that	the	images	were	not	consistently	superior	to	TTE	in	cats	as	in	dogs	or	humans.58,59	So	TTE	remains	the	gold	standard	for	evaluating	for	structural	and	functional	disease	and	changes	of	the	heart	in	cats.		
2.8	Common	presentation	in	cats	and	how	diagnostic	imaging	may	be	delayed	
	 A	common	presentation	for	feline	patients	with	heart	disease	is	respiratory	compromise	or	poor	cardiac	(diastolic	or	systolic)	function.	These	patients	are	often	given	intramuscular	(IM)	sedation	and	administered	flow-by	oxygen	or	put	in	an	oxygen	cage.	An	intravenous	(IV)	catheter	may	be	placed	to	administer	medications	with	quicker	onset	of	action	if	the	patient	can	tolerate	it.	During	this	time	a	history	is	obtained	and	the	patient	is	monitored	to	better	characterize	the	respiratory	pattern	and	for	any	improvement.	If	the	patient	has	a	history	or	pre-existing	disease	such	as	heart	disease/failure,	asthma	or	chylothorax,	the	appropriate	treatments	are	likely	applied	empirically	before	other	diagnostics	are	performed.	These	treatments	may	include	thoracocentesis	to	remove	fluid,	albuterol	for	asthmatic	cats,	or	furosemide	for	CHF.	As	discussed	earlier,	feline	patients	may	not	have	a	history	of	heart	disease	or	this	is	the	first	hospital	visit.	In	these	cases,	the	signalment,	physical	exam	(although	may	likely	be	minimal),	and	clinical	signs	and	
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characteristics	are	all	used	to	prioritize	the	differential	diagnoses.	If	the	patient	improves	or	is	stable	enough	to	perform	diagnostics,	thoracic	radiographs	is	usually	the	first	step	to	provide	a	global	overview	and	hopefully	provide	the	cause	of	the	clinical	signs	(i.e.	pulmonary	and/or	pleural	space	disease)	and	hopefully	insight	into	the	cardiac	versus	noncardiac	disease.	If	the	radiographs	are	unequivocal	for	congestive	heart	failure	then	treatment	(e.g.	furosemide)	may	be	adequate	until	an	echocardiogram	can	be	performed.	Another	common	scenario	is	the	radiographs	are	equivocal	and	other	conditions	such	as	primary	pulmonary	disease	or	pleural	space	disease	is	complicating	an	accurate	diagnosis.		
	 Commonly	these	patients	present	overnight	or	on	the	weekend.	The	presumptive	diagnosis	of	CHF	is	made	via	radiographs	and	they	wait	until	Monday	for	an	echocardiogram,	are	referred	to	a	cardiologist,	or	are	prescribed	medication	for	presumptive	HCM	diagnosis.	Referring	to,	or	evaluation	by,	a	cardiologist	allows	confirmation	of	the	presumptive	heart	disease	as	cause	of	the	clinical	condition,	characterizes	type	and	severity	of	the	disease	(which	includes	the	prognostic	factors),	and	provides	direction	of	treatment.	If	an	echocardiogram	is	not	pursued	or	a	cardiologist	is	not	available,	then	the	diagnosis	is	presumed	and	response	to	treatment	is	very	important	and	also	guides	therapy.	In	some	cases,	radiographs	and	echocardiography	are	not	performed	because	this	requires	manual	restraint	(more	so	in	echocardiography)	and	the	patient	is	at	too	high	of	a	risk	to	be	out	of	oxygen	or	is	easily	stressed.	
2.9	Prognostic	factors	in	cats	with	heart	disease	
	 As	mentioned	earlier,	but	not	explained,	echocardiography	also	affords	prognostic	indicators,	for	the	patient	and	to	the	client,	that	may	change	the	patient’s	therapy	and/or	
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prognosis.	This	is	also	especially	important	with	cases	that	likely	have	an	aortic	ATE.	Several	prognostic	indicators	have	shown	to	have	a	negative	effect	on	survival	in	cats	with	cardiomyopathy.	In	one	study	of	HCM,	decreased	left	atrial	and	ventricular	systolic	function,	and	marked	hypertrophy	over	9mm,	were	shown	to	have	increased	risk	of	cardiac	death.60	Increased	left	atrial	size	has	long	been	an	indicator	of	poorer	prognosis,	and	a	study	further	confirmed	that,	as	well	as	showed	decreased	survival	time	for	the	cats	in	CHF	and	with	an	ATE.60	This	study	also	showed	that	older	age,	absence	of	a	murmur,	presence	of	a	gallop	or	arrhythmia,	ventricular	wall	hypokinesis,	spontaneous	echocontrast,	thrombus,	absence	of	left	ventricular	outflow	obstruction,	and	a	restrictive	diastolic	filling	pattern	as	an	increased	risk	for	cardiac	death.18	The	cats	with	syncopal	episodes	did	better	than	the	cats	with	CHF	and	ATE,	which	is	different	from	other	and	later	reports	that	showed	these	patients	with	syncope	were	more	at	risk	for	sudden	death	than	other	cats.33	That	same	study	also	showed	similar	findings	that	the	presence	of	CHF	at	presentation	and	reduced	left	ventricular	fractional	shortening,	patients	were	likely	to	die	from	CHF	within	2	years	and	asymptomatic	cats	have	a	better	prognosis.33	The	cats	that	died	from	ATE	were	more	likely	to	have	an	ATE	(or	ATE	at	one	point)	and	decreased	left	atrial	factional	shortening.	One	textbook	says	that	there	is	a	high	likelihood	of	developing	congestive	heart	failure	within	months	to	2	years,	when	there	is	significant	left	atrial	dilation.58	Consistently,	the	presence	of	a	large	dilated	left	atrium	remains	a	high	risk	factor	for	CHF	and	ATE.	Other	prognostic	indicators	in	that	study	included	regional	wall	hypokinesis	relating	to	poor	fractional	shortening	and	the	presence	of	a	gallop	more	likely	with	ATE.33	Also	interestingly	in	that	study,	the	presence	of	arrhythmias	was	not	associated	with	ATE	like	in	humans,	but	was	associated	with	CHF	and	sudden	death.	They	also	state	that	the	median	survival	times	
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ranges	for	cats	are	so	variable	and	that	rapid	progression	of	structural	cardiac	changes	and	poor	owner	participation,	abilities,	and	insight	have	worse	prognosis.	A	very	recent	study	showed	RCM	has	a	poor	prognosis	in	short	and	long	term	compared	to	HCM	(RCM	median	survival	time	of	273	days	compared	to	HCM	of	865	days).61	So	overall,	my	take	away	is	that	there	are	many	factors	that	increase	the	risk	of	cardiac	death	and	that	asymptomatic	cats	have	a	better	prognosis.	Given	that	the	study	population	or	cats	that	present	on	an	emergency	basis	are	clinical,	the	asymptomatic	aspect	is	moot.	
2.10	Benefits	of	computed	tomography	in	feline	patients	
	 One	of	the	main	objectives	in	the	following	study	is	if	computed	tomography	can	be	a	safe	alternative	to	echocardiogram	when	not	available	–	to	be	performed	over	the	weekend	or	in	places	without	a	cardiologist	–	and	provide	accurate	and	prognostic	value	comparable	to	echocardiogram.	We	know	that	CT	can	provide	additional	information	and	there	are	many	causes	of	thoracic	disease.	Again	remembering	that	before	imaging	the	diagnosis	of	heart	disease	is	not	yet	obtained.	Could	CT	offer	benefits	that	would	otherwise	be	delayed?		
	 Well,	as	described	earlier,	in	humans	CTA	has	been	useful	as	an	alternative	to	evaluate	for	some	cardiac	diseases,	most	specifically	left	atrial	thrombi.	Computed	tomography	is	becoming	more	and	more	common	in	private	practice	(particularly	specialty	private	practices)	in	veterinary	medicine	and	also	in	practices	(hospitals)	with	no	in-house	cardiologist.	There	are	numerous	studies	on	cats	and	dogs	using	general	anesthesia	and	normal	contrast	injection	protocols	(1ml/lb.	or	2.2ml/kg	or	660mgI/kg)	to	characterize	thoracic	and	airway	changes,	however	our	goals	are	to	provide	emergency	based	awake	CT	
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scans	in	patients	that	cannot	undergo	heavy	sedation/anesthesia	nor	full	doses	of	IV	contrast.	A	few	CT	studies	have	been	performed	in	cats	and	dogs	that	have	been	stepping-stones	to	this	study	and	have	guided	this	research.	So	the	following	reports	will	focus	on	the	research	on	cats	that	mirrors	the	current	research	of	this	study,	meaning	awake	or	non-sedated	thoracic	CT	examinations	of	cats	using	the	VetMousetrap.TM	
	 The	first	study	on	awake	cats	by	Oliveira	et.	al.	2010,	used	a	Plexi-glass	restraining	device	called	the	VetMousetrap,TM	developed	by	veterinary	radiologist	Dr.	Robert	T.	O’Brien	at	the	University	of	Illinois	(see	Fig.	1).	The	device	is	a	transparent	acrylic	tube	with	a	diameter	of	21cm,	length	of	40cm,	thickness	of	5mm.	The	idea	was	to	allow	the	cats	to	be	imaged	without	direct	manipulation	as	would	be	required	for	radiographs	and	more	so	for	echocardiography.	The	front	of	the	device	has	a	small	slit	and	hole	that	allows	oxygen	tubes	to	be	placed	near	the	patients	head	as	well	as	catheters	to	be	used	for	contrast	administration	or	catheter	based	therapy.		
	 This	device	was	tested	in	two	phases	in	the	study	by	Oliveira	et	al	2010.	Phase	1	of	the	study	initially	tested	on	normal	awake	non-sedated	cats	for	changes	in	ambient	temperature,	carbon	dioxide	(CO2)	and	oxygen	levels.	Only	one	of	the	ten	moved,	and	the	other	nine	remained	quiet	and	visibly	unstressed	for	the	entirety	of	the	exam.	The	device	only	had	minimal	attenuation	(~54HU)	that	did	not	cause	artifacts.	The	temperature	increased	over	time	with	the	highest	at	29°C	with	no	increase	in	respiratory	rate.	The	inspired	oxygen	levels	increased	over	time	to	95%	fraction	of	inspired	oxygen	(FiO2)	using	an	oxygen	flow	rate	of	21ml/min	and	proved	to	work	as	an	oxygen	provider.	The	end	tidal	
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CO2	levels	increased	but	to	a	maximum	level	of	19mmHg	and	did	not	change	until	over	30	minutes.		
	 Phase	2	of	the	study	by	Oliveira	et	al	2010,	tested	four	different	dose-equivalent	CT	protocols	on	22	clinically	normal	awake	non-sedated	cats.	The	four	settings	were	as	follows:	low	and	high	kV	(80	and	120)	and	two	pitches	(0.562	and	1.75)	that	were	higher	and	lower	than	the	normal	range,	while	keeping	the	dose	index	volumes	the	same.	To	keep	the	doses	the	same,	manipulation	of	the	mAs	was	required.	The	detector	configuration	was	16x0.625mm	creating	a	beam	collimation	of	10mm.	Reconstructions	were	made	in	1.25mm	slice	thickness	in	a	detail	algorithm.	In	this	phase,	supplemental	foam	wedges	were	added	to	assist	in	keeping	the	cats	in	a	neutral	sternal	and	similar	position	to	the	other	cats.	This	phase	also	avoided	pre	scan	scout	images	by	keeping	the	VetMousetrapTM	in	the	same	position	on	the	table	for	each	cat	and	scanning	the	entire	device,	producing	whole	body	images.	Two	cats	were	excluded	due	to	signs	of	overt	stress.	The	mean	total	time	for	the	patient	to	be	at	the	CT	was	12.5	minutes	(mostly	were	below	15	minutes)	and	the	range	was	5-28	minutes.	After	completion	of	the	study	they	concluded	that	the	protocol	with	the	lower	kV	provided	better	contrast,	however	was	not	statistically	significant.	They	also	showed	that	motion	artifact	was	minimal,	only	5%	of	the	exams	had	over	10%	of	the	total	slices	with	motion	artifact	present.	Also,	even	though	there	was	a	statistically	significant	difference	between	high	and	low	pitches,	overall	there	was	absent	to	minimal	motion	artifact	in	a	majority	of	the	exams.	However	there	were	more	helical	and	windmill	artifacts	in	the	protocols	with	the	higher	pitch	and	essentially	minimally	present	to	absent	in	the	low	pitch	protocols.		
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	 This	study	by	Oliveira	et	al	2010,	changed	the	way	we	can	image	feline	patients	by	acquiring	excellent	diagnostic	quality	images	without	direct	manipulation	of	awake	non-sedated	cats.	This	was	in	a	relatively	short	period	of	time	in	a	device	that	did	not	alter	image	quality.	Also	this	device	was	a	presumably	low	stress	environment	compared	to	radiography	and	echocardiography	and	provided	adequate	oxygen	therapy	and	allows	catheter-based	therapy	as	well.	They	suggest	a	protocol	of	80kV,	130mAs,	0.5s	rotation	time,	0.562	pitch,	1.25mm	slice	thickness,	and	0.625mm	slice	thickness	reconstruction	interval	with	helical	based	CT	examination	of	the	thorax	in	a	cat.15		
	 The	second	follow	up	study	by	Oliveira	et	al	2011,	performed	CT	scans	of	54	clinical	cats	with	respiratory	disease	using	the	VetMousetrapTM	without	sedation	or	anesthesia,	with	similar	protocol	in	the	previous	study.	These	patients	had	a	range	of	diseases	with	lung	neoplasia	(n=9),	lower	airway	disease	(n=9),	and	congestive	heart	failure	secondary	to	cardiomyopathy	(n=9)	being	the	most	common	three.	The	severity	of	clinical	signs	varied	from	cough	to	cyanosis,	most	of	them	characterized	as	dyspneic,	and	no	complications	were	noted.	Oxygen	therapy	and	fluid	administration	was	continued	throughout	the	CT	scans.	This	proved	that	this	protocol	and	system	could	be	used	on	cats	with	respiratory	disease	and	on	an	emergency	basis.	However	they	did	have	four	cats	that	were	unable	to	have	a	CT	due	to	instability,	so	there	is	some	limitation	dependent	on	the	patient’s	clinical	status.	This	study	further	proved	(like	many	others)	that	CT	is	more	sensitive	for	identifying	the	cause	of	the	clinical	signs	compared	to	radiography.	For	example	they	reached	a	correct	diagnosis	in	77.8%	of	the	cats	on	CT	and	58%	on	radiography	and	some	of	these	conditions	were	lymphadenopathy,	feline	lower	airway	disease,	bronchiectasis,	and	cardiomegaly	(including	congestive	heart	failure).	The	CT	scan	also	provided	
	 30	
additional	information	over	radiographs	in	74%	of	the	cats	and	these	changes	included	pulmonary	metastases/masses,	sternal	and	cranial	mediastinal	lymphadenopathy.14	This	was	in	large	part	due	to	CT	with	contrast	performed	in	19	of	these	cats.	Although,	the	study	does	not	mention	if	the	patients	with	heart	failure	received	IV	contrast.	So	CT	not	only	is	more	sensitive	for	identifying	abnormalities,	it	is	more	accurate	for	obtaining	the	correct	diagnosis.	Furthermore	IV	contrast	can	be	used	in	addition	to	the	previously	described	protocol	without	complications.		
	 The	next	study	by	Rodriguez	et	al	2014,	expanded	on	the	previous	studies	and	looked	at	using	a	microdose	of	IV	contrast	(0.1ml/lb.	or	0.22ml/kg	or	66mgI/kg)	to	evaluate	cardiac	angiography	in	normal	cats.	The	contrast	dose	used	was	from	the	author’s	preliminary	data	that	provided	adequate	images.	These	cats	were	lightly	sedated	with	butorphanol	(0.3mg/kg).	The	purpose	was	to	be	able	to	use	these	normal	parameters	for	future	cases	as	well	as	assess	visibility	of	the	different	cardiac	compartments.	Meaning	the	prospective	patients	would	likely,	or	could	have	cardiac	disease	and	this	may	prevent	fluid	overload,	congestive	heart	failure	or	further	compromise	unstable	patients.	The	CT	protocol	was	similar	to	the	two	previously	described.	The	contrast	was	mixed	with	equal	parts	saline	and	delivered	via	hand	injection	over	6	seconds.	CT	attenuation	values	(HU)	and	contrast	enhancement	of	the	cardiac	walls	as	well	as	the	contrast	within	the	chambers	was	quantified	for	normal	values.	This	study	also	allowed	subjective	differentiation	of	the	cardiac	chambers	(specifically	all	four	chambers)	using	this	microdose,	and	suggest	this	protocol	would	be	useful	for	cats	with	suspected	left	sided	congestive	heart	failure.16		
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	 One	other	unpublished	study	performed	by	some	of	the	same	author’s	in	the	aforementioned	reports,	looked	at	cats	in	congestive	heart	failure	using	a	similar	protocol.	In	at	least	one	of	the	CT	examinations	a	contrast	filling	defect	was	noted	in	the	left	auricle,	suspicious	of	a	thrombus	(clot),	and	thus	spawned	the	idea	of	this	project.	The	next	section	will	outline	my	research	materials	and	methods	to	compare	echocardiography	and	computed	tomographic	angiography	for	identifying	and	characterizing	cardiac	clots	in	cats	with	heart	disease.		
	 	
		 													
	 32	
CHAPTER	3	METHODOLOGY			 We	prospectively	recruited	cats	between	2014	and	2016	with	heart	disease	if	they	fit	the	following	inclusion	criteria	on	echocardiogram	(GE	Vivid	E9,	GE	Vingmed	Ultrasound,	Horton,	Norway)	performed	by	our	staff	cardiologist	(RF):	(1)	spontaneous	echocontrast	“smoke”	and/or	(2)	a	thrombus	(clot)	within	a	chamber	of	the	heart.	Within	24	hours	from	the	echocardiogram	the	patient	underwent	contrast	CT	of	the	thorax,	or	was	removed	from	the	study.	No	specific	clinical	signs	were	required.	The	Institutional	Animal	Care	and	Use	Committee	at	the	University	of	Illinois	approved	our	study	protocol.	
	 Most	of	the	patients	were	lightly	sedated	with	butorphanol	(doses	ranged	from	0.2-0.4mg/kg)	either	intravenously	(IV)	or	intramuscularly	(IM)	prior	to	the	CT	scan	and/or	echocardiogram.	An	IV	catheter	(20-22	gauge)	was	placed	within	the	cephalic	vein.	For	the	echocardiograms,	the	standard	left	and	right	parasternal	echocardiographic	views	were	obtained	including	the	oblique	left	apical	parasternal	long-axis	view,	which	highlighted	the	left	atrium	and	left	auricle.	A	diagnosis	of	cardiac	disease	along	with	smoke	and/or	a	thrombus	were	identified.		
	 A	thoracic	contrast	CT	using	a	16-slice	helical	scanner	(GE	Lightspeed	16	Slice	CT,	Milwaukee,	WI.)	was	performed	with	the	patient	in	a	Plexi-glass	positioning	device	(VetMousetrapTM)	in	sternal	recumbency.	Initial	scans	were	pre-contrast	routine	full	thoracic	survey	series	with	1.25mm	slice	thickness,	0.5s	rotation	time,	small	scanned	field	of	view	(SFOV),	15cm	display	field	of	view	(DFOV),	100kVp,	240	mA	in	detail	algorithm.		Secondly,	a	continuous	phase	(4	runs	through	heart)	post	contrast	study	of	the	heart	(from	
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cranial	to	caudal	and	then	caudal	to	cranial,	and	so	on)	was	performed	using	1.25mm	slice	thickness,	0.5s	rotation	time,	small	SFOV,	15cm	DFOV,	100kVp,	320	mA	(increased	from	survey)	in	standard	algorithm	and	a	pitch	of	0.9.	After	approximately	a	couple	minutes,	a	dynamic	(Cine-loop)	study	was	then	performed.	The	protocol	used	the	16	detectors	to	obtain	20mm	range	of	image	acquisition	simultaneously,	centered	on	the	region	of	the	left	atrium	and	auricle	for	20	seconds.	The	CT	parameters	were	1.25mm	slice	thickness,	0.5s	rotation	time,	small	SFOV,	15cm	DFOV,	100kVp,	340	mA	(increased	from	survey	and	continuous	phase)	in	standard	algorithm.	The	region	of	the	left	auricle	was	identified	on	the	pre-contrast	study	by	the	radiology	resident	or	faculty	(See	Fig.	2).	
	 The	IV	nonionic	iodinated	contrast	medium	(Omnipaque	300TM	Iohexol	injection,	GE	Healthcare,	Princeton,	NJ)	was	delivered	by	hand	injection	over	15-20	seconds	for	both	studies	(continuous	phase	and	dynamic)	and	started	simultaneously	with	image	acquisition.	Hand	injections	were	chosen	over	power	injection	because	a	minimum	dose	of	10	mls	was	required	for	the	injector.	The	IV	contrast	dose	administered	was	double	the	microdose	used	in	a	previous	study16	to	increase	the	visibility	of	the	margins	of	the	clot	and	cardiac	walls.	For	example,	a	patient’s	dose	was	0.2ml/lb.	mixed	with	equal	parts	sterile	saline,	which	remained	a	1/5th	of	the	standard	IV	contrast	dose	of	1ml/lb.	The	same	dose	was	repeated	at	the	beginning	of	the	dynamic	(Cine-loop)	study.	The	total	IV	contrast	dose	for	each	patient	was	0.4ml/lb.,	which	is	below	half	the	standard	dose	of	1	ml/lb.	The	total	time	to	set	up	and	run	the	CT	examinations	was	approximately	5-10	minutes	but	this	is	an	estimate,	as	this	parameter	was	not	assessed.		
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	 All	the	images	(echocardiograms	and	CT	examinations)	were	anonymized,	randomized	via	a	random	number	generator,	and	evaluated	by	two	board-certified	radiologists	(RTO,	MH)	and	cardiologists	(RF,	JV).	The	CT	and	echo	images	were	not	compared	to	each	other	at	the	time	of	review	(i.e.	the	echocardiograms	with	the	dynamic	CT	studies,	or	multiphase)	to	avoid	bias.	All	of	the	CT	images	were	provided	as	original	(unaltered)	DICOM	images	and	manipulation	of	the	window	width	and	level	(i.e.	switching	from	soft	tissue	to	lung	window)	was	permitted.	The	reviewers	were	given	a	tutorial	on	how	to	open	the	dynamic	images	and	were	allowed	to	scroll	through	the	detector	range	(20mm).	Only	transverse	CT	images	were	provided	for	review,	which	included:	(1)	pre-contrast	full	thorax,	(2)	continuous	phase	images	over	the	whole	heart	and	(3)	the	dynamic	(Cine-loop)	studies	centered	over	the	left	atrium	and	auricle.	Only	the	oblique	left	apical	parasternal	long-axis	views	were	evaluated	by	the	reviewers	(this	included	3-4	short	video	clips	per	anonymized	patient).	However	one	patient	had	clots	within	the	right	heart,	so	a	right	parasternal	short	axis	view	of	the	right	ventricular	outflow	tract	was	used.	The	reviewers	were	given	a	questionnaire	for	the	echo	and	CT’s	to	list	specific	findings	(See	Table	1).	For	the	CT	scan	they	were	asked	to	answer	if	the	following	were	present	or	absent:	chamber	enlargement	(right	or	left,	atrial	or	ventricular),	overall	cardiac	enlargement,	SEC,	and	thrombi.	If	present,	then	they	described	location	and	brief	description	of	size.	Any	additional	findings	in	the	CT	studies	such	as	pleural	effusion	or	pulmonary	disease	were	evaluated	in	the	same	manner	and	assigned	severity	(mild,	moderate,	severe).	Artifacts	such	as	motion	or	contrast	streaming	were	also	graded	as	mild,	moderate,	or	severe,	if	present	and	overall	CT	diagnosis	was	provided.	For	the	echo’s,	only	
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the	presence	of	smoke	or	clot	were	asked.	If	present	then	location	and	brief	description	of	severity	were	described.	
	 On	each	of	the	dynamic	CTA	studies,	regions	of	interest	(ROI)	were	placed	within	the	left	atrium,	aorta,	right	atrium	and	left	auricle	(at	a	level	of	the	suspected	clot	or	where	the	clots	typically	were	visualized	within	the	left	auricle).	The	level,	size	and	position	were	chosen	by	the	author	(KV)	but	the	size	and	shape	of	the	ROI’s	were	subjectively	consistent	between	all	of	the	patients.	The	average	Hounsfield	Units	(HU)	of	these	ROI’s	were	collected	over	the	20	seconds	of	continuous	scanning	and	put	onto	a	time	attenuation	curve	(TAC).	Mean	average	intensities	with	3mm	thick	slabs	were	used	to	acquire	more	smoothly	defined	attenuation	curves.	The	raw	data	was	evaluated	to	assess	quantifiably	if	the	mean	HU’s	within	left	auricles	with	clots	was	statistically	significantly	decreased	in	contrast	enhancement	(or	attenuation	values)	compared	to	the	left	atrium	with	smoke.		
	 Statistical	analyses	for	the	categorical	data	were	performed	with	commercially	available	software.a	Calculation	of	sensitivity	and	specificity	for	observer’s	interpretation	of	post-contrast	CT,	dynamic	(Cine)	CT,	and	echo	images	for	evidence	of	clot	presence	was	compared	to	the	reference	standard	of	original	echocardiographic	exam	by	author	(RF).	Multiple	observers’	interpretation	was	utilized	as	a	mean	and	rounded	to	the	nearest	integer.	When	observer’s	answers	were	indeterminate	then	these	were	treated	by	exclusion	from	this	calculation.	Intra-class	correlation	coefficient	(ICC)	was	calculated	for	the	reliability	analysis	between	the	3	or	4	observers	for	each	modality,	echo	and	CT	respectively.	Kappa	coefficients	were	also	calculated	for	radiologists	and	cardiologists	for	post-contrast	and	cine	CT	as	well	as	for	the	radiologists	for	the	echocardiograms.	Statistical	
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analysis	of	the	continuous	data	(dynamic	cine-loop	ROI’s)	was	performed	with	Microsoft	Excel	(2010).	A	2-sample	independent	t-test	was	used	to	compare	between	the	patients	with	clots	and	smoke	using	the	difference	of	the	highest	mean	attenuation	values	or	Hounsfield	Units	(HU)	of	the	left	auricle	and	atrium.	
a	IBM	Corp.	Released	2013.	IBM	SPSS	Statistics	for	Macintosh,	Version	22.0.	Armonk,	NY:	IBM	Corp.	
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CHAPTER	4	RESULTS		
	 Fourteen	cats	were	included	in	the	study,	diagnosed	with	either	smoke	(n=7)	and/or	clot	(n=7)	within	the	heart,	based	on	echocardiography	by	a	cardiologist	(RF)	as	the	reference	standard.	Two	of	the	clots	(one	of	which	was	highly	suspected	to	be	present)	at	the	time	of	examination	were	not	reproducible	in	the	images	given	to	the	reviewers,	so	the	echocardiographic	image	sets	with	clots	totaled	five.	The	reference	number	for	clots	for	the	CT	images	remained	at	seven	given	the	original	diagnosis	for	those	two	cats	included	a	clot	within	the	left	auricles.	(See	Table	2	to	see	all	the	patient	info).	We	did	not	want	to	create	any	bias	or	false	positives	for	the	CT	images	given	that	the	images	likely	cover	more	of	the	heart	(and	the	left	auricle)	than	echo	and	may	identify	the	clot	if	present.	All	fourteen	cats	had	the	same	echocardiographic	and	CT	protocols.	The	only	other	difference	was	a	patient	with	a	suspected	FATE	that	had	an	additional	microdose	to	confirm	a	(filling	defect)	thrombus	within	the	aortic	trifurcation	during	an	abdominal	study.	No	complications	were	noted	with	any	patients	using	this	protocol,	although	specific	parameters	were	not	assessed.	
	 Six	out	of	the	seven	(85.7%)	clots	were	visible	on	CTA	as	filling	defects	by	at	least	one	reviewer	using	the	continuous	phase	and	5/7	(71.4%)	clots	in	the	dynamic	(CINE)	studies	(See	Table	3).	For	one	the	clots	that	was	missed	in	the	dynamic	phase,	at	least	one	observer	had	an	indeterminate	response	(meaning	unsure	or	possibly	present).	The	sensitivity	and	specificity	for	detection	of	a	clot	on	continuous	phase	was	71.4%	for	both.	
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The	intra-class	correlation	coefficient	(ICC)	was	0.58	(moderate	agreement)	and	the	kappa	values	were	0.26	(fair	agreement)	for	the	radiologists	and	0.45	(moderate	agreement)	for	the	cardiologists.	For	the	dynamic	studies,	the	sensitivity	and	specificity	were	57.1%	and	85.7%,	respectively.	The	ICC	was	0.64	(moderate	agreement)	between	all	reviewers	and	the	kappa	values	were	.36	(fair	agreement)	for	the	radiologists	and	.47	(moderate	agreement)	for	the	cardiologists.	(See	Table	4).	No	clots	(filling	defects)	were	visible	on	pre	contrast	images.		
	 Three	clots	were	confirmed	on	necropsy	within	the	dilated	right	heart	of	one	patient	with	severe	cardiomyopathy,	cardiac	fibrosis,	chronic	infarctions,	and	os	cordis	(skeletal	bone	within	the	heart).	Two	other	patients	had	necropsies,	one	was	a	smoke	patient	confirmed	to	have	no	clots.	The	other	patient	had	a	presumed	(highly	suspected)	left	auricular	clot	(on	echocardiography	and	CTA)	and	FATE.	The	necropsy	showed	no	left	auricular	clot	but	did	confirm	large	thromboembolism	within	the	aortic	trifurcation.	The	locations	of	the	clots	on	CTA	within	the	chambers	of	the	heart	corresponded	to	the	echocardiographic	location	in	all	cases	(one	within	the	left	auricle	of	six	patients	and	three	within	the	right	heart	of	one	patient).	Most	(5/7)	of	the	left	auricular	clots	on	transverse	CTA	exam	appeared	as	fairly	well	defined,	irregularly	marginated,	mildly	variably	sized	non-contrast	enhancing	filling	defects	occupying	the	left	auricle	from	its	distal	aspect.	The	border	of	the	clots	that	occupied	the	left	auricles	adjacent	to	the	contrast	was	always	mildly	concave	(see	Fig.	3	which	compares	clot	and	smoke	images).	Six	of	these	clots	were	within	the	distal	aspect	of	the	left	auricle	and	the	three	right	heart	clots	randomly	bordered	the	endocardial	surface	of	the	right	ventricle	and	right	ventricular	outflow	tract	(see	Fig.	4).	The	shape	of	the	clots	mildly	varied	between	CTA	compared	to	echocardiogram.	On	
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echocardiography	they	were	irregularly	marginated	and	mostly	incompletely	filled	the	left	auricle	with	surrounding	or	intermixed	regions	of	anechoic	blood	or	echogenic	smoke.	However,	on	the	CTA	exams	these	commonly	homogenously	filled	the	left	auricle.	The	two	patients	with	a	small	thrombus	and	suspected	thrombus	(within	the	original	echocardiographic	diagnosis	but	only	smoke	on	echo	images	given	to	the	reviewers)	displayed	a	small	filling	defect	similar	to	the	appearance	of	the	other	small	thrombi	and	were	detected	by	at	least	one	of	the	reviewers	in	both	cases.	This	likely	indicated	that	the	CT	was	able	to	identify	that	clot	rather	than	a	false	positive,	since	the	original	examination	either	had	a	clot	(n=1)	or	highly	suspected	a	clot	(n=1).			 The	echocardiographic	sensitivity	to	identify	a	clot	was	100%	but	the	specificity	was	67%.	The	ICC	for	all	three	observers	was	0.38	(poor	agreement)	and	the	kappa	statistic	for	the	radiologists	was	0.39	(fair	agreement).	All	of	the	clots	(5/5)	were	visualized	by	all	of	the	reviewers	(i.e.	no	reviewer	missed	a	clot)	but	all	of	the	examiners	had	at	least	one	false	positive	(both	the	radiologists	had	multiple	false	positives).	
	 Diagnoses	in	these	cats	with	cardiac	disease	were	all	cardiomyopathies,	including	hypertrophic	(n=9),	unclassified	(n=4)	and	restrictive	(n=1).	Final	diagnoses	for	the	heart	diseases	were	based	off	of	echocardiography	(n=11)	and	necropsy	(n=3).	Other	findings	included	one	patient	with	severe	diffusely	thickened	and	hyperattenuating	interlobular	septa	throughout	the	lung	parenchyma	on	noncontrast	CT,	consistent	with	diffuse	severe	idiopathic	pulmonary	fibrosis	(see	Fig.	5).	One	cat	had	poorly	defined	soft	tissue	attenuating	thickening	of	the	bronchial	walls,	and	asthma	was	presumed.	Eight	patients	had	signs	consistent	with	congestive	heart	failure	diagnosed	via	echocardiography	and	concurrent	radiographs	(5	with	pulmonary	edema	and	8	with	pleural	effusion).	All	of	these	
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patients	were	diagnosed	with	cardiac	disease	and	failure	on	the	pre	contrast	images.	The	pericardial	fat	even	allowed	accurate	identification	of	left	atrial	and	auricular	enlargement	between	all	the	viewers	to	make	the	diagnosis	before	contrast	was	administered.	The	pulmonary	edema	commonly	manifested	as	mild	ill-defined	patchy	interstitial	pattern	(ground	glass	appearance)	to	marked	patchy	ill	defined	increased	attenuation	with	border	effacement	of	the	surrounding	vessels	and	air	bronchograms	(alveolar	pattern)	within	multiple	lung	lobes	(see	Fig.	6).	The	location	was	variable	and	was	sometimes	more	peripheral.	Some	of	the	marked	alveolar	patterns	appeared	mass-like	in	the	lung	window,	however	on	the	soft	tissue	window	was	non-contrast	enhancing.	In	all	of	the	pulmonary	edema	cases	there	was	ill-defined	perivascular	soft	tissue	attenuation	causing	border	effacement	of	the	vessels	and	at	least	mild	venous	congestion	was	present	in	all	the	cases	with	congestive	heart	failure.	Minimal	pericardial	effusion	was	present	within	9	cats	(diagnosed	by	echocardiography)	but	none	were	identified	on	CTA.	A	contrast	filling	defect	was	identified	on	CTA	in	one	patient	and	a	corresponding	thrombus	was	confirmed	at	the	aortic	trifurcation	on	necropsy.	On	CT	the	filling	defect	extended	into	the	terminal	aorta,	and	external	and	internal	iliac	arteries	(See	Fig.	7).	
	 The	age	ranges	of	the	patients	were	from	1-17	years	old	(median	age	of	10).	There	were	9	male	castrated	and	5	female	spayed	cats.	The	most	common	breed	was	domestic	shorthair	(n=9),	then	Sphynx	(n=3),	domestic	medium	hair	(n=2),	and	one	mixed	breed.	The	presenting	complaints	of	the	cats	mildly	varied	with	the	most	common	being	an	increased	respiratory	rate	and	effort	(n=8).	Three	presented	for	difficulty	walking	or	possible	saddle	thrombus	and	one	was	a	recheck	heart	disease	that	was	nonclinical	at	the	time	of	exam.	The	clinical	signs	ranged	from	one	doing	well	to	open	mouth	breathing.	Most	
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of	them	had	increased	respiratory	effort	and	rate	(n=7)	and	two	had	open	mouth	breathing	and	dyspnea.	The	two	cats	with	open	mouth	breathing	were	imaged	after	they	were	stabilized	and	respiratory	character	improved.	Three	cats	were	neurologically	inappropriate	with	ataxia	and	paresis	or	-plegia;	one	had	central	vestibular	signs.	These	patients	were	suspected	to	have	arterial	thromboembolism	causing	these	clinical	signs.		
	 The	ROI’s	obtained	from	the	dynamic	studies	were	compared	between	the	clot	(n=7)	and	smoke	patients	(n=6).	One	of	the	patients	file	was	corrupted	and	the	values	were	not	obtainable.	Another	patient,	the	exam	only	recorded	half	of	the	data.	The	null	hypothesis	is	that	the	group’s	(clot	vs.	smoke)	differences	of	highest	attenuation	values	(HU)	would	be	the	same	(or	statistically	not	different).	A	confidence	interval	of	0.95	and	p=0.05	was	used	to	assess	statistical	significance	between	the	two	categories.	The	one	tailed	t-value	was	1.8125	and	the	P-value	was	0.0209.	The	null	hypothesis	was	rejected,	indicating	a	statistical	difference	between	the	clot	and	smoke	groups.	The	clot	group	had	significantly	larger	HU	difference	between	the	left	auricle	and	left	atrium	compared	to	the	groups	with	smoke.	Specifically	the	left	auricle	had	lower	attenuation	values	compared	to	the	left	atrium.		
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CHAPTER	5	DISCUSSION			 All	but	one	of	the	clots	(6/7)	identified	on	echocardiography	were	identified	as	contrast	filling	defects	on	the	post	contrast	CT	studies	by	at	least	one	of	the	reviewers.	The	highest	sensitivity	for	detection	was	71.4%	in	the	continuous	phase	post	contrast	studies.	The	only	clot	that	was	not	detected	by	any	of	the	reviewers	was	smaller,	incompletely	filled	the	left	auricle,	and	had	contrast	surrounding	the	clot	within	most	of	the	left	auricle	–	unlike	the	other	five	clots.	This	likely	indicates	that	identification	of	the	clot	is	viewer	and	location	dependent.	Meaning	that	a	smaller	clot,	one	that	incompletely	fills	the	left	auricle,	or	is	more	mobile	with	surrounding	contrast,	may	be	missed.	Identification	is	also	likely	dependent	on	a	viewer’s	experience,	not	necessarily	on	years	of	experience,	but	more	so	one	that	has	seen	more	of	these	cases	and	has	given	more	attention	to	the	normal	left	auricular	appearance	on	CTA.	The	poor	to	moderate	inter-observer	agreement	using	the	ICC	and	kappa	statistics	further	confirm	this.	Giving	the	reviewers	a	normal	left	atrial	study	or	examples	of	CTA	images	with	and	without	a	clot	likely	would	have	increased	the	sensitivity,	specificity	and	inter-observer	agreement,	since	this	is	a	novel	region	of	interest	in	the	heart	to	evaluate.	The	movement	of	the	filling	defects	within	a	single	study	(i.e.	the	left	auricle	moving	in	and	out	of	the	image	plane)	may	have	contributed	to	some	reviewers	missing	some	of	the	clots	because	they	assessed	for	a	persistent	filling	defect.	Also	within	the	dynamic	studies	the	reviewers	were	asked	to	toggle	through	the	2cm	of	slices	at	10	images/sec,	which	could	also	decrease	the	sensitivity.	The	highest	specificity	was	85.7%	on	the	dynamic	studies	(not	too	dissimilar	from	the	continuous	phase	at	71.4%).	The	pectinate	
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muscles	within	the	left	auricle	pose	a	problem	as	they	cause	undulating	filling	defects	extending	from	the	wall	that	may	be	confused	as	clots	and	likely	contributed	to	some	of	the	false	positive	diagnoses	in	these	cats.	Another	factor	is	the	movement	of	the	heart	during	the	exam,	which	causes	motion	artifact	and	partial	averaging	of	the	wall,	which	also	likely	contributed	to	the	false	positives.	Nonetheless,	this	does	not	negate	that	all	but	one	of	the	clots	identified	on	echo	were	visible	as	contrast	filling	defects	in	the	CTA	studies.	Furthermore,	the	one	that	was	missed	is	visible	on	both	the	continuous	phase	and	dynamic	studies	by	the	lead	author.	Again	this	was	likely	missed	by	the	reviewers	due	to	the	unfamiliarity	of	assessing	this	appendage	and	dissimilarity	of	the	clot	from	the	others.	The	more	well	defined	clots,	ones	that	homogenously	filled	the	left	auricle,	as	well	as	the	larger	ones	were	seen	by	all	of	the	reviewers	and	consistently.	The	authors	believe	that	the	more	cardiac	disease	is	studied	(such	as	this	research)	and	used	with	CTA,	the	sensitivity,	specificity	and	observer	agreement	for	identifying	cardiac	clots	will	increase.		
	 The	continuous	phase	studies	were	more	sensitive	than	the	dynamic	studies	(71.4%	compared	to	57.1%),	likely	because	all	of	the	reviewers	were	unfamiliar	with	or	had	not	used	the	4-D	tools	to	evaluate	the	heart	in	real	time.	Allowing	them	to	toggle	through	the	image	planes	while	playing	the	loops	in	real	time	likely	hindered	their	ability	to	detect	the	clots.	The	dynamic	study	was	limited	to	2cm	(due	to	our	16	detector	limit)	and	in	almost	every	image	the	entire	left	atrium	and	auricle	could	not	completely	be	within	this	coverage	(e.g.	image	set).	The	author	centered	on	the	tip	of	the	left	auricle	and	the	CT	scanned	1cm	cranial	and	caudal	to	this	location.	The	images	also	contained	more	motion	artifact	and	partial	averaging,	all	of	which	likely	contributed	to	poor	detection	and	increased	indeterminate	responses.	So	as	these	CT	dynamic	studies	become	more	user	friendly	and	
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commonly	applied,	this	will	likely	increase	the	detection	accuracy.	The	continuous	phase	studies	had	less	motion	artifact,	with	subjectively	better	spatial	resolution.		
	 Another	interesting	finding	was	the	low	specificity	(67%)	for	reviewers	to	rule	out	clots	echocardiographically	compared	to	CTA	(lowest	was	71.4%).	The	reviewers	commonly	had	false	positives	(and	more	common	with	the	radiologists).	The	results	from	this	study	and	feedback	from	the	reviewers	show	that	identification	and	differentiation	from	smoke	on	echo	can	be	challenging	in	some	cases,	especially	with	a	severe	amount	of	smoke.	To	say	that	CTA	is	more	specific	than	echo	would	be	difficult	to	extrapolate	and	further	investigation	and	research	is	needed.	Only	having	the	selected	echo	clips	and	the	nature	of	retrospectively	viewing	another	cardiologist’s	images	is	a	limitation	of	this	study.	One	benefit	of	CTA	may	be	the	ability	to	evaluate	the	entire	left	atrium	and	auricle,	which	can	be	difficult	echocardiographically,	especially	in	cases	with	severe	left	atrial	and	auricular	enlargement.	In	contrast,	the	sensitivity	was	high	(100%)	and	none	of	the	reviewers	missed	a	clot.	This	is	not	surprising	given	that	echocardiography	is	the	reference	standard	for	diagnosing	clots	but	also	reassuring,	as	it	was	the	reference	standard	for	this	study.	Some	of	the	clots	characterized	on	echo	were	mildly	different	in	size	and	shape	(mostly	smaller	on	echo)	compared	to	the	CTA	but	were	all	localized	accurately	within	the	heart	by	CTA	(n=6	in	the	left	auricle,	n=1	each	in	the	right	atrium,	RVOT	and	right	ventricle).	The	authors	believe	this	mild	size	and	shape	discrepancy	is	likely	due	to	pooling	of	blood	(stasis)	around	the	clot	because	of	the	poor	cardiac	contractility	and	ability	to	eject	blood	out	of	the	left	auricle	from	around	the	clot.	To	the	author’s	knowledge,	there	is	no	distinguishing	characteristic	of	smoke	on	CT	so	this	was	not	assessed	on	the	CT	images.	Also,	severe	smoke	or	stasis	within	the	left	auricles	without	clot	formation	but	with	a	filling	
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defect	on	CTA	is	possible	given	that	the	stasis	surrounding	the	clot	increases	the	size	of	the	filling	defect.	Further	research	in	patients	with	severe	smoke	and	concomitant	conditions	like	atrial	fibrillation	compared	to	the	Hounsfield	Units	may	be	useful.		
	 We	found	that	CT	was	able	to	provide	some	valuable	prognostic	indicators	and	comorbidities,	even	though	the	amount	of	cardiac	information	provided	by	CT	scans	(such	as	function)	does	not	compare	to	echocardiography.	Although	prognostic	factors	such	as	fractional	shortening,	regional	wall	hypokinesis,	and	left	ventricular	function	cannot	be	evaluated,	CT	provided	multiple	prognostic	indicators	in	most	of	the	patients	including:	atrial	or	ventricular	clots	(6/7),	severe	left	atrial	enlargement	(n=13),	cardiomegaly	(n=14),	congestive	heart	failure	(n=5	pulmonary	edema,	n=8	pleural	effusion)	and	confirmed	a	thromboembolism	in	the	aortic	trifurcation	(n=1).	These	findings	were	very	consistent	among	the	reviewers	so	statistics	was	not	performed.		
	 There	is	very	little	literature	on	the	CT	appearance	of	pulmonary	edema	in	cats,	likely	because	these	patients	are	usually	screened	before	CT	exam	for	heart	disease	and	patients	at	most	institutions	and	hospitals	are	under	general	anesthesia,	precluding	CT	exams.	The	CT	findings	of	pulmonary	edema	in	these	cats	were	similar	to	the	previously	reported	variable	radiographic	appearance	and	shared	commonalities	described	in	the	results.62	This	study	confirms	and	adds	to	the	literature	of	CT	appearance	of	pulmonary	edema	in	cats.	The	CT’s	also	provided	additional	comorbidities	including	severe	diffuse	pulmonary	fibrosis,	presumed	asthma	and	arterial	thromboembolism.	The	distribution	of	the	cat	with	presumed	idiopathic	pulmonary	fibrosis	was	similar	to	a	previous	report	and	literature,	showing	diffusely	thickened	and	hyperattenuating	interlobular	septa.45,53,63	All	of	
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the	reviewers	accurately	identified	overall	cardiac	and	specific	chamber	enlargement	on	both	pre	and	post	contrast	CT	images,	although	all	the	cats	had	heart	disease.	Specific	sizes	of	changes	(e.g.	left	atrium,	interventricular	septum)	and	type	of	cardiac	disease	(e.g.	hypertrophic	cardiomyopathy)	were	not	evaluated	in	this	study.	A	good	future	study	would	be	to	compare	measurements	such	as	left	atrial	to	aortic	(LA:AO)	ratio	on	CTA	to	echocardiography	in	patients	with	cardiac	disease	in	this	type	of	setting	(i.e.	without	general	anesthesia).		
	 CT	failed	to	identify	all	cases	(n=9)	with	pericardial	effusion	even	though	the	amount	was	termed	trivial	by	the	cardiologist.	Previous	reports	and	text	consider	that	CT	may	be	accurate	in	identifying	pericardial	effusion	however	only	a	small	amount	of	pericardial	effusion	over	50mls	in	a	human	study	was	detectable.	Furthermore	the	veterinary	literature	is	in	dogs	which	all	arguably	were	larger	patients	and	had	a	larger	amount	of	effusion.53,64,65	These	cats	only	had	a	very	minimal	amount,	many	had	bordering	pleural	effusion,	and	the	wall	of	the	pericardium	is	only	1-2mm	thick	in	normal	cats.53	Also	there	is	likely	motion	artifact	and	partial	volume	averaging	given	the	cats	are	awake	and	non-gated	CT	was	used.	So	the	poor	sensitivity	of	the	CT	scan	to	detect	trivial	pericardial	effusion	is	not	surprising.	
	 The	dynamic	studies	showed	there	is	a	statistical	difference	of	the	left	atrial	and	auricular	mean	HU’s	between	clots	and	smoke.	This	is	further	proof	that	the	filling	defects	within	the	left	auricles	(and	right	heart)	are	true.	However,	previous	research	in	humans	has	shown	that	quantifying	the	left	auricle	attenuation	values	is	less	sensitive	and	specific	compared	to	subjective	visual	identification.39	The	clinical	applicability	of	measuring	the	
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HU’s	within	these	regions	is	likely	low.	This	is	especially	true	given	that	a	low	specific	(threshold)	number	was	not	reached	to	accurately	assess	if	a	clot	was	present	and	running	a	TAC	for	clinical	cases	would	be	time	consuming.	Also,	the	left	auricle	seems	to	have	consistent	lower	attenuation	values	than	left	atrium	normally	(or	in	cases	without	a	clot)	(See	Fig.	8).	This	protocol	was	standardized	as	much	as	possible	by	the	author,	but	placement	and	size	of	the	ROI’s	is	user	dependent	and	subjective.	Further	standardization	of	the	placement	and	size	is	likely	needed	but	this	study	can	be	used	a	starting	point.	Future	studies	using	this	technique	with	more	cases	are	needed.	Also,	using	a	larger	row	of	detectors	may	provide	more	useful	information	for	this	type	of	study	and	other	conditions	in	addition	to	cardiac	disease.	
	 The	study	protocol	using	the	doubled	microdose	over	15-20	seconds	proved	safe	to	use	in	awake	cats	with	severe	heart	disease	and	congestive	heart	failure.	The	author	does	not	propose	that	this	protocol	would	be	innocuous	in	all	cats	with	severe	cardiac	or	respiratory	disease	–	the	decision	would	be	patient	and	clinician	dependent.	As	such,	the	two	cats	with	severe	dyspnea	in	this	study	were	stabilized	before	the	exams.	Nevertheless	most	of	the	cats	were	symptomatic	during	the	exam	with	no	visible	or	overt	cardiovascular	changes	noted	post	examination.	This	study	adds	to	the	literature	that	CTA	can	be	useful	and	safe	in	a	patient	with	cardiac	disease	and	failure	that	may	have	diagnostic	imaging	delayed	due	to	instability	or	no	access	to	a	cardiologist.	The	intent	of	this	study	was	never	to	replace	echocardiography.	In	fact,	many	times	the	patient’s	clinical	signs	may	be	equivocal	and	CTA	can	now	be	used	in	these	cases.	Cardiac	disease	can	present	similar	to	many	other	thoracic	diseases	and	the	diagnosis	of	heart	disease	is	not	made	until	imaging	is	performed.	Since	the	cardiac	size	and	diagnosis	on	the	pre	contrast	images	were	very	
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accurate	for	heart	disease	and	failure,	this	protocol	can	be	substituted	in	for	the	patients	that	require	contrast.	A	future	study	would	be	to	use	this	protocol	for	patients	presenting	with	primary	extra-cardiac	disease	(such	as	pulmonary	neoplasia)	and	concomitant	cardiac	disease	precluding	the	use	of	a	normal	contrast	dose	–	to	evaluate	if	the	microdose	will	provide	enough	contrast	to	discern	neoplasia	from	other	diseases.		
	 Only	mild	artifacts	were	found	in	this	study,	mostly	pertaining	to	streaking	artifact	within	the	right	atrium	due	to	contrast	mixing	and	motion	artifact.	Neither	of	them	hindered	interpretation	of	the	images	and	were	all	deemed	good	diagnostic	studies	by	the	reviewers,	similar	to	previous	studies.14–16	
	 There	are	some	additional	limitations	in	this	study.	The	echo	images	only	provided	three	to	four	clips	of	a	specific	region	of	the	heart	(chosen	by	one	of	the	authors)	and	were	not	representative	of	the	full	study	or	of	the	left	atrium	and	left	auricle.	This	is	why	there	was	a	discrepancy	of	the	number	of	clots	in	the	echo	and	CT	images.	This	also	makes	the	ability	of	determining	the	sensitivity	and	specificity	a	little	more	difficult	and	convoluted,	because	the	presence	of	the	clot	is	dependent	on	the	original	echocardiographic	exam.	Also,	post	mortem	exams	were	only	performed	on	a	few	of	the	cases	to	confirm	the	presence	of	the	clots	and	in	one	case	with	a	left	auricular	clot	on	echo,	no	clot	was	found	on	necropsy.	The	patient	also	had	an	arterial	thromboembolism,	so	the	left	auricular	clot	could	have	dislodged	by	the	time	of	the	necropsy.	Other	possibilities	are	that	specific	attention	to	the	heart	was	not	specified	on	the	post	mortem	request	or	the	echo	and	CT	identified	a	false	positive.	The	CT	images	were	only	reviewed	in	original	transverse	planes	and	the	ability	to	make	multiplanar	reconstructions	may	have	improved	detection.	Only	a	small	number	of	
	 49	
cats	(n=14)	and	only	with	heart	disease	(abnormal	cats)	were	used	in	the	study.	Comparing	these	images	to	normal	may	have	given	the	reviewers	better	accuracy	and	reference	to	left	auricular	anatomy,	such	as	pectinate	muscle	appearance.	Normal	cats	are	the	standard	control	group	for	most	studies	and	may	have	allowed	a	better	control	for	this	study.	However	assessing	for	cardiac	clots	in	normal	hearts	would	likely	not	be	performed	in	a	clinical	basis.	
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CHAPTER	6	
CONCLUSION	
	 In	conclusion,	CTA	can	be	a	safe	and	informative	diagnostic	imaging	modality	in	awake	cats	with	severe	cardiac	disease	and	congestive	heart	failure	using	our	altered	microdose	protocol	and	VetMousetrap.TM	CTA	can	detect	cardiac	chamber	enlargement	and	clots,	although	smaller	clots	or	ones	incompletely	filling	the	left	auricle	may	be	missed.	Both	dynamic	and	continuous	image	acquisition	can	be	useful,	but	continuous	phase	may	currently	be	more	sensitive.	CTA	also	provided	important	prognostic	indicators	including	congestive	heart	failure	(pulmonary	edema,	pleural	effusion),	severe	left	atrial	dilation,	cardiac	clots	and	arterial	thromboembolism.	
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CHAPTER	7	FIGURES	AND	TABLES		
	Fig.	1.	Dr.	Robert	O’Brien	and	a	feline	patient	within	the	VetMouseTrapTM	he	developed	on	the	CT	scanner	table.	(https://news.illinois.edu/blog/view/6367/204877#image-1)	
	 52	
	Fig.	2.	Pre	contrast	transverse	CT	at	the	level	of	the	left	auricle	(white	arrow)	in	a	soft	tissue	window.	Patient’s	right	is	on	the	left.	Soft	tissue	window	(WL:	40,	WW:	350).			
	Table.	1.	(cont.)	
Pa#ent	ID	
Smoke	(yes	or	no,	
indeterminate)	
If	Smoke:	mild,	moderate,	severe;	descriptor	
(LMNOSS)	
Clot	(yes	or	no,	indeterminate);	descriptor	
(LMNOSS)	
A	
B	
C	
D	
E	
F	
G	
H	
I		
J	
K	
L	
M	
N	
Name	of	Evaluator:	
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	Table	1.	(cont.)	Questionnaire’s	given	to	the	reviewers	for	echocardiography	and	CTA,	respectively.		
Image	set	#	
Filling	defect	-	Clot	(yes	or	no,	
indeterminate);	Descrip<on	
(LMNOSS)	
Subjec<ve	cardiac/chamber	
enlargement	(mild,	moderate,	
severe)	
Addi<onal	ﬁndings	(e.g.	pleural	fuid,	
pulmonary	edema,	vessel	changes,	
pulmonary	nodules,	lymph	nodes,	
pericardial	ﬂuid)	
Ar<facts	(e.g.	mo<on,	
streaking)	and	severity	
(mild,	moderate,	severe)	 Diagnoses	
Cat	1	
Cat	2	
Cat	3	
Cat	4	
Cat	5	
Cat	6	
Cat	7	
Cat	8	
Cat	9	
Cat	10	
Cat	11	
Cat	12	
Cat	13	
Cat	14	
Cat	15	
Cat	16	
Cat	17	
Cat	18	
Cat	19	
Cat	20	
Cat	21	
Cat	22	
Cat	23	
Cat	24	
Cat	25	
Cat	26	
Cat	27	
Cat	28	
Cat	29	
Cat	30	
Cat	31	
Cat	32	
Cat	33	
Cat	34	
Cat	35	
Cat	36	
Cat	37	
Cat	38	
Cat	39	
Cat	40	
Cat	41	
Cat	42	
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	Table	2.	(cont.)Patient	data.	
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*=On	original	echo	or	highly	suspected,	but	not	on	echo	key	Table	2.	(cont.)	Patient	data.		
	 56	
	Table	3.	Results	from	reviewers	for	clot	detection	on	CTA	and	echocardiography.		
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Post	Contrast	
CT	
	 	 	 	 	 	
ICC	all	4	
observers	
0.58	 95%	CI:	0.053	to	0.84	 p=0.018	 Moderate	reliability	 	
Kappa	2	
radiologists	
0.26	 	 	 	 	 	
Kappa	2	
cardiologists	
0.45	 	 	 	 	 	
	 	 	 	 	 	 	Observers	 	 CT	post	
Key	
	 	 	 	
	 No	 Yes	 	 	 	 	No	 5	 2	 7	 	 Sensitivity	 0.714285714	Yes	 2	 5	 7	 	 Specificity	 0.714285714		 7	 7	 14	 	 	 	
Cine	CT	 	 	 	 	 	 	
ICC	all	4	
observers	
0.64	 95%	CI:	
0.18	to	
0.87	
p=0.007	 Moderate	
reliability	
	
Kappa	2	
radiologists	
0.36	 	 	 	 	 	
Kappa	2	
cardiologists	
0.47	 	 	 	 	 	
	 	 	 	 	 	 	
Observers	 	 CT	post	
Key	
	 	 	 	
	 No	 Yes	 	 	 	 	
No	 6	 3	 9	 	 Sensitivity	 0.571428571	
Yes	 1	 4	 5	 	 Specificity	 0.857142857	
	 7	 7	 14	 	 	 	Table	4.	(cont.).				
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Echo	 	 	 	 	 	 	
ICC	all	4	
observers	
0.38	 95%	CI:	-0.52	to	0.78	 p=0.14	 Poor	reliability	 	
Kappa	2	
radiologists	
0.39	 	 	 	 	 	
	 	 	 	 	 	 	
Observers	 	 Echo	Key	 	 	 	 		 No	 Yes	 	 	 	 	No	 6	 0	 6	 	 Sensitivity	 1	Yes	 3	 5	 8	 	 Specificity	 0.666666667		 9	 5	 14	 	 	 		Table	4.	(cont.).	Inter-observer	agreement,	sensitivity	and	specificities	for	echo	and	CT	studies	(including	continuous	phase	and	dynamic).							
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	Fig.	3.		Transverse	CTA	(A)	of	a	patient	with	a	dilated	left	atrium	and	left	auricle	with	a	large	filling	defect	(presumed	clot)	(white	arrow)	occupying	most	of	the	left	auricle.	(B)	The	corresponding	oblique	left	apical	parasternal	long-axis	echocardiographic	image	of	the	left	auricle	with	corresponding	clot	that	is	similar	in	appearance	conforming	to	and	occupying	most	of	the	left	auricle.	The	white	arrowheads	outline	the	external	margins	of	the	left	auricle.	LA=left	atrium,	LV=left	ventricle.	The	second	set	of	images	(C,D)	is	of	a	patient	with	severe	left	atrial	enlargement	and	only	smoke	identified	on	echo.	Transverse	thoracic	CTA	(C)	and	oblique	left	apical	parasternal	long-axis	view	of	the	left	auricle	(D)	with	severely	dilated	left	atrium	and	left	auricle	with	no	filling	defects	noted	within	the	left	auricle	(white	arrow).	The	asterisk	highlights	the	smoke	within	the	left	atrium.		
C D 
* 
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	Fig.	4.	Transverse	CTA	(A)	of	the	thorax	showing	the	two	well	defined	irregularly	marginated	filling	defects	(clots	confirmed	on	necropsy)	(white	arrows)	within	the	right	ventricle.	Right	parasternal	short	axis	view	at	the	right	ventricular	outflow	tract	showing	the	two	rounded	well-defined	echogenic	clots	within	the	lumen	of	the	right	ventricle	bordering	the	endocardial	surface.	
A B 
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	Fig.	5.	Transverse	noncontrast	CT	of	the	thorax	at	the	level	of	the	apex	of	the	heart	of	a	cat	with	suspect	idiopathic	pulmonary	fibrosis.	Note	the	thickened	and	hyperattenuating	bands	outlining	the	interlobular	septa	(black	arrow)	diffusely	throughout	all	of	the	lung	lobes.	CT	images	are	in	a	lung	window.	WL:-500,	WW:1400.				
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	Fig.	6.	Transverse	noncontrast	CT	images	of	the	thorax	at	the	level	of	the	mid	to	caudal	heart,	all	with	suspected	pulmonary	edema	(black	arrows).	(A)	There	is	patchy	ill-defined	increased	attenuation	within	multiple	lung	lobes	without	border	effacement	of	the	vessels.	(B)	Larger	focal	region	of	marked	irregularly	marginated	and	ill	defined	increased	attenuation	with	border	effacement	of	the	vessels	and	air	bronchograms,	almost	creating	a	mass	like	appearance	within	the	left	caudal	lung	lobe.	(C)	Focal	ill	defined	nondependent	increased	attenuation	within	the	periphery	of	the	left	caudal	lung	lobe.	(D)	Bilateral	marked	patchy	alveolar	pattern	within	the	caudal	lung	lobe	centered	on	the	caudal	lobar	vessels	but	also	ventrally	located.	Pulmonary	venous	congestion	is	present	in	all	images	(only	delineated	in	the	final	image	(D)	by	a	black	arrowhead).	WL:-500,	WW:1400.	
A B 
C D 
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	Fig.	7.	Reformatted	dorsal	plane	CTA	image	of	the	caudal	abdomen	showing	a	well-defined	contrast	filling	defect	(white	arrow)	within	the	caudal	descending	aorta	that	extends	into	the	external	and	internal	iliac	arteries.				
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	Fig.	8.	(cont.)	
A B 
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	Fig.	8.	(cont.)	(A)	Regions	of	interest	placed	within	the	heart	on	a	transverse	dynamic	CTA	image.	Very	similar	ROI’s	were	placed	in	all	patients.	Time	attenuation	curves	(TAC)	represented	numerically	(A,B)	and	graphically	(C)	in	a	patient	with	a	clot.	In	this	patient	you	can	see	that	the	left	Auricle	(Lau	–	black	line)	is	markedly	lower	in	attenuation	throughout	the	curve	compared	to	the	left	atrium	(LA	–	blue	line).	(D)	TAC	of	a	patient	with	smoke,	note	that	the	left	auricle	is	closer	matching	that	attenuation	of	the	left	atrium,	but	slightly	lower.				 							
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